News tagged headline

.Pharmacy TLD Featured in Interview With Neustar

Carmen A. Catizone, MS, RPh, DPh, NABP executive director/secretary, discussed the .pharmacy domain name and its benefits for the domain name industry, registrants, and public health during an interview with Neustar, a company that provides top-level domain (TLD) registry services.

Read More →

ACPE Installs New Board Members for 2016-2022 Term of Service

The Accreditation Council for Pharmacy Education (ACPE) has announced the installation of the new ACPE Board of Directors for the 2016 to 2022 term of service.

Read More →

New Research Shows PDMPs Associated With Reduction in Opioid Overdose Deaths

State prescription drug monitoring programs (PDMPs) were connected to the prevention of nearly one opioid-related overdose death every two hours on average nationwide, reports a new study led by Vanderbilt University. 

Read More →

Pharmacists Most Trusted Group in Health Care, According to Survey

Pharmacists were rated as the most trusted health care providers, according to a new consumer health survey.

Read More →

NABP Seeks Qualified Nominee to Fill District 6 Executive Committee Member Position

NABP seeks nominations for a member or administrative officer to fill the District 6 representative position on the NABP Executive Committee.

Read More →

New York Governor Signs Comprehensive Legislative Package to Address Heroin and Opioid Crisis

As part of the 2016 legislative session, Governor Andrew M. Cuomo signed a comprehensive package of legislation to combat the heroin and opioid crisis in the state of New York. 

Read More →

North Carolina and Texas Sign Legislation to Make Naloxone More Accessible to Patients

New legislation in North Carolina and Texas make naloxone, the opioid overdose reversal drug, more accessible to patients.

Read More →

Delaware Law Requires ID to Buy Certain Cough Medicines

A new Delaware law restricts the sale of over-the-counter (OTC) medicines containing dextromethorphan (DXM) to those aged 18 and older.

Read More →

New Hampshire Pharmacies May Establish Drug Take-Back Programs Under New Law

Retail pharmacies in New Hampshire are authorized to establish pharmaceutical drug take-back programs if their program meets certain federal requirements. 

Read More →

US Department of Justice Drops Charges Related to Illegal Distribution of Prescription Drugs Against FedEx

Charges against FedEx Corporation for knowingly shipping illegal online prescription drugs have been dropped at the request of federal prosecutors.

Read More →

Thousands of Rogue Online Drug Sellers Shut Down During Operation Pangea IX

As part of Operation Pangea IX, the ninth annual International Internet Week of Action (IIWA), Food and Drug Administration (FDA) took action against 4,402 websites that illegally sell potentially dangerous, unapproved prescription drugs to United States consumers. 

Read More →

Illegal Online Drug Outlets Pose Health and Financial Risks to Older Adults; New Campaign Offers Tips to Avoid Rogue Websites

Low prices and the convenience of shopping online are two driving factors for buying medications on the Internet, making older Americans easy targets for rogue entities illegally distributing medications online.

Read More →

Alaska Regulates Sale of Dextromethorphan Products to Adults, Requires Prescription for Persons Under 18 Years of Age

The sale of products containing dextromethorphan in Alaska is restricted to individuals 18 years of age or older under a new law.

Read More →

St Louis Mayor Signs Bill to Establish PDMP in the City

A prescription drug monitoring program (PDMP) will be established in the city of St Louis, MO, according to a bill signed into law by Mayor Francis Slay.

Read More →

Investigators Seize Misbranded and Mislabeled Drug Products Sold by Unauthorized Sellers at St Paul Marketplace

Misbranded and mislabeled medications, injectable drugs, and needles were seized from two booths at a southeast Asian marketplace in St Paul, MN, by the Ramsey County sheriff’s office on March 23, 2016.

Read More →

College Study Investigates Ease of Illegal Access to Opioids Online, Finds Most Sites Studied Violate Online Pharmacy Consumer Protection Act

A research project by students of the Fisher College Criminal Justice Division in Boston, MA, found various types of opioids easy to locate and obtain illegally through multiple online platforms. 

Read More →

Website Domains of Fake Online Drug Outlets Seized by Federal Authorities

Sixty-seven domain names of commercial websites involved in the illegal sale and distribution of counterfeit and prescription drugs had seizure orders executed against them, according to an announcement by the US Department of Justice. 

Read More →

Pharmacies in West Virginia Will Be Allowed to Dispense Opioid Antagonists Pursuant to Protocol Under New Law

Pharmacies in West Virginia will be able to dispense naloxone, the opioid overdose reversal drug, pursuant to a protocol beginning June 10, 2016. 

Read More →

New Data Shows Decline in Opioid Prescribing but Rise in Fatal Overdoses

Read More →

Pharmacists in New Jersey Would Be Able to Dispense Certain Contraceptives Under Proposed Law

Pharmacists in New Jersey would be able to dispense self-administered hormonal contraceptives pursuant to a standing order under a proposed New Jersey bill.

Read More →

Hal Wand, MBA, RPh, Begins Term as NABP President During the Association’s 112th Annual Meeting

Hal Wand, MBA, RPh, began his term as president of the National Association of Boards of Pharmacy® (NABP®) during the Final Business Session of the Association’s 112th Annual Meeting, May 14-17, 2016, in San Diego, CA.

Read More →

Jeanne D. Waggener, RPh, DPh, Elected NABP President-elect at Association’s 112th Annual Meeting

Jeanne D. Waggener, RPh, DPh, was elected to serve as the 2016-2017 president-elect of the National Association of Boards of Pharmacy® (NABP®) during the Association’s 112th Annual Meeting, May 14-17, 2016, in San Diego, CA. 

Read More →

Susan Ksiazek, RPh, Elected NABP Treasurer at Association’s 112th Annual Meeting

Susan Ksiazek, RPh, was elected to serve as the 2016-2017 treasurer of the National Association of Boards of Pharmacy® (NABP®) during the Association’s 112th Annual Meeting, May 14-17, 2016, in San Diego, CA.

Read More →

Timothy D. Fensky, RPh, FACA, Elected to Serve as Member of Executive Committee at NABP 112th Annual Meeting

Timothy D. Fensky, RPh, FACA, was elected to serve a three-year member term, representing District 1, on the Executive Committee of the National Association of Boards of Pharmacy® (NABP®) during the Association’s 112th Annual Meeting, May 14-17, 2016, in San Diego, CA.

Read More →

Caroline D. Juran, RPh, Elected to Serve as Member of Executive Committee at NABP 112th Annual Meeting

Caroline D. Juran, RPh, was elected to serve a three-year member term, representing District 2, on the Executive Committee of the National Association of Boards of Pharmacy® (NABP®) during the Association’s 112th Annual Meeting, May 14-17, 2016, in San Diego, CA.

Read More →

Gary Dewhirst, RPh, DPh, Re-Elected to Serve as Member of NABP Executive Committee at Association’s 112th Annual Meeting

Gary Dewhirst, RPh, DPh, was re-elected to serve a three-year member term, representing District 5, on the Executive Committee of the National Association of Boards of Pharmacy® (NABP®) during the Association’s 112th Annual Meeting, May 14-17, 2016, in San Diego, CA.

Read More →

FDA Holds Meeting to Assess ER/LA Opioid Analgesics REMS Requirement of Prescriber Training

The FDA Drug Safety and Risk Management (DSaRM) Advisory Committee and the Anesthetic and Analgesic Drug Products Advisory Committee (AADPAC) met on May 3-4, 2016, to discuss the risk evaluation and mitigation strategy (REMS) for extended-release (ER) and long-acting (LA) opioid analgesic medications. 

Read More →

National Vaccine Safety Surveillance Program Available for Reporting Adverse Events

The Vaccine Adverse Event Reporting System (VAERS) eSubmitter program, a national vaccine safety surveillance program cosponsored by the Centers for Disease Control and Prevention (CDC) and FDA, is available for the reporting of any clinically significant adverse event that occurs after the administration of any vaccine licensed in the US.

Read More →

FDA Updates Outdated Requirements for Biological Products Standards

FDA has issued a direct final rule that revises and removes certain general biological products standards to account for new methods of manufacture and testing often associated with new biological products.

Read More →

Bing Revises Online Pharmacy Advertising Policy to Recognize .Pharmacy TLD

Online pharmacies and drug information sites approved by the National Association of Boards of Pharmacy® (NABP®) to register a .Pharmacy Top-Level Domain (TLD) are now eligible to advertise prescription medications with Microsoft Bing Ads in the United States and Canada effective April 13, 2016. 

Read More →

Maine to Require Providers Use E-Prescribing and Check Prescription Monitoring Data for Opioids, Benzodiazepine; Law Includes New Limits for Opioid Prescribing

Prescribers and dispensers in Maine will be required to check prescription monitoring information when prescribing and dispensing a benzodiazepine or an opioid medication.

Read More →

Two States Propose Regulations Related to Telemedicine Practice

A health care provider who possesses an unrestricted license to practice medicine in Louisiana and a patient at two locations separated by distance would be able to interact via a two-way video or audio transmission under a proposed Louisiana law.

Read More →

Reminder: DEA Take-Back Day Is Saturday, April 30

Consumers will have the opportunity to dispose of unneeded or unwanted medications at a Drug Enforcement Administration (DEA) National Prescription Drug Take-Back Day collection site this Saturday, April 30, 2016. 

Read More →

FDA Publishes Three Draft Guidance Documents Related to Compounding Human Drugs

Food and Drug Administration (FDA) released three draft guidance documents related to human drug compounding under the Federal Food, Drug, and Cosmetic Act (FD&C Act). 

Read More →

Sign or Sticker to Be Developed for Washington Pharmacies That Prescribe and Dispense Contraceptives

Once available from the Washington Pharmacy Quality Assurance Commission, a sticker or sign may be displayed at Washington pharmacies if their pharmacists are authorized to prescribe and dispense contraceptives under a collaborative drug therapy agreement. 

Read More →

Minnesota Pharmacies Could Take Back Prescription Medicines Under Proposed Legislation

Pharmacies in Minnesota would be able to collect and dispose of controlled substances (CS) and non-CS under a proposed bill (Senate File (SF) 1425). 

Read More →

Consumers Are Unable to Identify Common NSAIDs, Unaware of Associated Risks

Consumers who use non-steroidal anti-inflammatory drugs (NSAIDs) are unaware of the risks related to using these pain medications, according to a new survey. 

Read More →

NABP Debuts Redesigned Print and Electronic Newsletters

This new design for NABP e-News complements NABP’s redesigned and renamed printed newsletter, Innovations, which is mailing to members and subscribers this week.

Read More →

FDA Issues Draft Guidance for Industry on Biosimilar Labeling

Food and Drug Administration (FDA) has published a draft guidance, Labeling for Biosimilar Products, to assist applicants in developing draft labeling for proposed biosimilar products.

Read More →

HHS Proposes Increasing Buprenorphine Patient Limit for Medication-Assisted Treatment

With the goal of expanding access to medication-assisted treatment (MAT), United States Department of Health and Human Services (HHS) has proposed a rule that would permit qualified physicians to prescribe buprenorphine, the opioid use disorder treatment medication, to as many as 200 patients.

Read More →

Pharmacists in Florida May Dispense Opioid Antagonist Pursuant to Standing Order

Pharmacists in Florida may dispense an emergency opioid antagonist pursuant to a nonpatient-specific standing order prescribed by a health care provider, according to a recently passed law.

Read More →

Certain Utah Pharmacies to Offer Naloxone Under Collaborative Practice Agreement

Naloxone, the opioid overdose reversal drug, is available at Associated Food Stores retailer’s pharmacies in Utah under a collaborative pharmacy practice agreement with prescribers.

Read More →

Iowa Bill Would Bring Telepharmacies to Rural and Underserved Areas

A pharmacist could remotely supervise a pharmacy technician practicing at an approved telepharmacy site in Iowa and provide pharmaceutical care services, including drug regimen review and patient counseling, through the use of technology, according to new legislation that passed in the Iowa Senate and in the Iowa House of Representatives. 

Read More →

FDA Requires Class-Wide Labeling Changes for Immediate-Release Opioid Analgesics

Topics: Prescription drug abuse and Fda

Food and Drug Administration (FDA) is requiring class-wide safety labeling changes for immediate-release (IR) opioid pain medications, which will include a new boxed warning about the serious risks of misuse, abuse, addiction, overdose, and death. 

Read More →

FDA Publishes Draft Guidance for Industry on Developing Generic Opioid Analgesics

Topics: Prescription drug abuse and Fda

FDA has issued a draft guidance for industry to support the development of generic opioid analgesics that are formulated to deter abuse. 

Read More →

Pharmacists in Indiana Allowed to Deny the Sale of Ephedrine or Pseudoephedrine Products

Topics: Pharmacists and Pseudoephedrine

Pharmacists in Indiana may refuse to sell ephedrine or pseudoephedrine to a purchaser if the pharmacist determines that the drugs are not medically necessary.

Read More →

More Older Patients at Risk for Drug-Drug Interaction, Indicates New Study

Topics: Patient safety

About 15% of older patients are potentially at risk for a major drug-drug interaction compared with an estimated 8.4% in 2005, indicates a new study. 

Read More →

Over 200 Health Centers Awarded Funding to Treat Opioid Abuse in Underserved Communities

Topics: Prescription drug abuse

US Department of Health & Human Services (HHS) has announced that 271 health centers in 45 states, the District of Columbia, and Puerto Rico have been granted $94 million in Affordable Care Act funding to improve and expand substance abuse services, with a specific focus on treatment of opioid use disorders in underserved populations.

Read More →

New York Law Mandates Electronic Prescribing for Controlled Substances and Non-Controlled Substances

Topics: Electronic prescriptions

Prescribers in the state of New York must issue electronic prescriptions directly to a pharmacy according to a new law.

Read More →

Two Products Voluntarily Recalled Due to Safety Issues

Topics: Compounding and Fda

Teva Pharmaceuticals of North Wales, PA, is recalling one lot of amikacin sulfate injection, USP, 1 gram/4 mL (250 mg/mL) vials because the presence of glass has been identified in one vial.

Read More →

Idaho Bill Seeks to Lower Age for Children to Be Immunized by Pharmacists

Topics: Vaccinations

Pharmacists in Idaho would be able to prescribe and administer immunizations to children who are six years of age or older, under proposed legislation passed in the Idaho House of Representatives. 

Read More →

New FDA Drug Info Rounds Training Video Reviews Keeping Medications Safe in Emergency Situations

Topics: Pharmacists and Fda

FDA Drug Info Rounds, a series of online videos, provides important and timely drug information to practicing clinical and community pharmacists so they can help patients make better decisions. 

Read More →

FDA Issues Compliance Policy Guidance Related to Dispensers’ Transactions With First Responders

Topics: Fda

Food and Drug Administration (FDA) issued a new guidance for industry indicating the agency does not intend to take action against a dispenser who transfers ownership of a product directly to a first responder without providing product tracing information to the first responder.

Read More →

Prescription Drug Diversion Addressed During DEA Meeting With Drug Supply Chain Industry Leaders

Topics: Diversion and Dea

Prescription drug supply chain industry leaders met with United States Drug Enforcement Administration (DEA) Acting Administrator, Chuck Rosenberg, and Deputy Assistant Administrator, Lou Milione, to discuss ways to reduce pharmaceutical diversion while maintaining legitimate commerce and patient access.

Read More →

Public Health Officials Petition FDA for Black Box Warnings and Medication Guides Regarding Serious Risks of Combining Opioids With Benzodiazepines

Topics: Adverse drug events and Fda

A petition submitted to Food and Drug Administration (FDA) requests that the agency add a black box warning on all medications in the opioid and benzodiazepine classes to warn prescribers and patients about a reduced margin of safety and increased risk of fatal overdose when these classes of medication are used together. 

Read More →

Proposed Federal Bill Would Fund State Development of Standing Orders for Dispensing Opioid Overdose Reversal Drug and Education Programs

Topics: Prescription drug abuse

Federal legislation that would provide funding to states for the development of standing orders for pharmacies to dispense opioid overdose reversal medication has been introduced by United States Representative Robert J. Dold (R-IL).

Read More →

Legal Briefs | SOS: Surrender or Sell

Topics: Pharmacy

Administrative matters are commonly resolved through a settlement or consent agreement whereby the parties memorialize their understandings through a formal contract.

Read More →

Access to Naloxone Becoming Widespread Across Ohio and Kentucky

Topics: Over the counter and Prescription drug abuse

New state regulations in Ohio and Kentucky allow pharmacies to dispense naloxone, the opioid overdose reversal drug, pursuant to a physician-approved protocol.

Read More →

Wisconsin Pharmacies Participate in Pilot Project to Help Make Medicine Labels Easier to Read

Topics: Prescription label

Forty-six Wisconsin pharmacies are participating in a two-year pilot project to increase medication adherence by using patient-centered prescription drug labels.

Read More →

Multifaceted Federal Bill Addressing Opioid Abuse Under Review by Legislators

In response to the national epidemic of prescription opioid abuse and heroin use, a bill addressing prevention, education, law enforcement, and treatment efforts is under review in the United States Legislature.

Read More →

Study Examines Consumer Educational Initiatives Raising Awareness About Internet Drug Outlets, Includes NABP Data

Topics: Counterfeit drugs and Buying medicine online

Reviewing the efforts of 13 stakeholder organizations, a new study examines educational programs aimed to raise consumer awareness about the risks of entities that illegally distribute medications online.

Read More →

Walgreens to Work with Regulators to Increase Access to Naloxone and Implement Drug Take-Back Program

Topics: Medication collection program disposal and Prescription drug abuse

Walgreens will work with regulators to increase access to naloxone, the opioid overdose reversal drug, at its pharmacies in 35 states and the District of Columbia, and the company will also install medication disposal kiosks in over 500 drug store locations in 39 states and the District of Columbia, by the end of the year.

Read More →

New FDA Drug Info Rounds Training Video Reviews MedWatch Tips and Tools

Topics: Fda

Food and Drug Administration (FDA) Drug Info Rounds, a series of online videos, provides important and timely drug information to practicing clinical and community pharmacists so they can help patients make better decisions.

Read More →

President Obama Calls for Funding to Help Expand Access to Opioid Addiction Treatment

Topics: Prescription drug abuse

President Barack Obama’s 2017 budget calls for a twofold approach to address the prescription opioid abuse and heroin use epidemic. 

Read More →

FDA Calls for Review of Opioids Policy, Announces Action Plan

Topics: Prescription drug abuse, Pain management, and Fda

As part of a broad national campaign to address opioid abuse, dependence, and overdose, Food and Drug Administration (FDA) Deputy Commissioner for Medical Products and Tobacco, Dr Robert Califf, along with other FDA leaders, developed a comprehensive action plan to reassess the agency’s approach to opioid medications.

Read More →

DEA “360 Strategy” Aims to Address Prescription Opioid Abuse, Heroin Use, and Drug Trafficking With Pilot Program in St Louis

Topics: Prescription drug abuse and Dea

Drug Enforcement Administration (DEA) continues to implement the “360 Strategy,” a comprehensive plan to address prescription opioid abuse, heroin use, and related violent crime, by launching the pilot program in a second city, St Louis, MO.

Read More →

USP Published Chapter on Handling Hazardous Drugs in Health Care Settings

Topics: Compounding

A new general chapter, <800> Hazardous Drugs – Handling in Healthcare Settings, has been published as part of a suite of health care quality standards included in the United States Pharmacopeia — National Formulary (USP—NF) by the United States Pharmacopeial Convention (USP) to help prevent and/or limit hazardous drug exposures in health care. 

Read More →

Baxter Announces Nationwide Recall of Select Lots of IV Solutions

Topics: Compounding

Baxter International, Inc, is voluntarily recalling four lots of intravenous solutions to the hospital level because of the potential for leaking containers and particulate matter. 

Read More →

R Thomas Marketing, LLC, in Conjunction With Just Enhance, LLC, Recalls Multiple Dietary Supplements Due to Undeclared Sildenafil

Topics: Over the counter and Fda

R Thomas Marketing, LLC, issued a nationwide recall of multiple dietary supplements to the consumer level because FDA testing identified that the products contain sildenafil (a PDE-5 inhibitor), the active ingredient in an FDA-approved drug for erectile dysfunction, which is not listed on the product labels.

Read More →

Substantial Decline Seen in Number of Hydrocodone Combination Product Prescriptions Dispensed From US Pharmacies

Topics: Controlled substances, Prescription drug abuse, and Dea

In the year after the United States Drug Enforcement Administration (DEA) rescheduled hydrocodone combination products from Schedule III to Schedule II, 26.3 million fewer hydrocodone combination product prescriptions were written and 1.1 billion fewer hydrocodone combination product tablets were dispensed.

Read More →

FDA Offers Webinars on Online Drug Information Resources for Students and Clinicians

Topics: Federal regulations and Fda

FDA’s Division of Drug Information in the Center for Drug Evaluation and Research is presenting a series of continuing education webinars targeted toward students and health care providers who wish to learn more about FDA and drug regulation.

Read More →

White House Announces Effort to Combat Heroin and Opioid Abuse in Rural Areas

Topics: Prescription drug abuse

Department of Agriculture Secretary Tom Vilsack has been appointed by President Barack Obama to lead an interagency initiative to address heroin and opioid abuse, among other critical issues, in rural communities.

Read More →

Abbott’s Compounding Pharmacy Recalls All Lots of Sterile Compounded Products Distributed Within California

Topics: Compounding

Abbott’s Compounding Pharmacy is recalling all lots of sterile compounded products within expiry that were distributed to patients, physician offices, clinics, and veterinarians within California between January 1, 2015, and January 14, 2016. 

Read More →

Over-the-Counter Cough Syrup Recalled Due to Unidentified Morphine

Topics: Over the counter

Master Herbs, Inc, of Pomona, CA, is recalling all lots of Licorice Coughing Liquid cough syrup in 100 mL bottles to the consumer level because of the presence of morphine, which is not declared in the product’s ingredients.

Read More →

Texas Compounding Facility Ordered to Stop Manufacture and Distribution of Products

Topics: Compounding and Fda

Downing Labs, LLC, of Dallas, TX, is prohibited from manufacturing, holding, or distributing drugs under a consent decree of permanent injunction entered against the facility by a federal court. 

Read More →

Over-the-Counter Children’s Medicines Recalled Due to Incorrect Dose Markings

Topics: Over the counter

Perrigo Company is voluntarily recalling two lots of children’s guaifenesin grape liquid cough medicine (100 mg/5 mL) and three lots of children’s guaifenesin DM cherry liquid cough medicine (100 mg guaifenesin and 5 mg dextromethorphan HBr/5 mL) sold in 4 oz bottles. 

Read More →

Grant to Supply Massachusetts First Responders With Opioid Overdose Reversal Drug

Topics: Prescription drug abuse

First responders in 31 Massachusetts communities will receive naloxone, the opioid overdose reversal drug, through a $700,000 state grant. 

Read More →

Robberies of Vans Delivering Drugs to Pharmacies and Hospitals On the Rise

Topics: Controlled substances

Robberies of vans or couriers that deliver drugs, primarily controlled substances, to hospitals and pharmacies are occurring more frequently, and tend to involve violence. 

Read More →

Baxter International, Inc, Recalls Two Lots of IV Solutions Due to Particulate Matter

Topics: Compounding and Fda

Baxter International, Inc, is voluntarily recalling two lots of intravenous solutions to the hospital/user level because of the presence of particulate matter identified as an insect.

Read More →

Hospira, Inc, Recalls One Lot of Magnesium Sulfate in Water for Injection Due to Incorrect Barcode Labeling on Primary Container

Topics: Compounding and Fda

Hospira, Inc, announced a voluntary recall of one lot of magnesium sulfate in water for injection (0.325 mEq Mg⁺⁺/mL) 40 mg/mL 2 g total, 50 mL to the user level because a customer report confirmed an incorrect barcode on the primary bag labeling. 

Read More →

Texas to Implement New PIC Requirements for Nonresident Pharmacies

Topics: Compounding and Pharmacists

Effective on September 1, 2016, every Texas nonresident pharmacy (class E) and nonresident pharmacy engaged in compounding sterile preparations (class E-S) must have a pharmacist-in-charge (PIC) who is licensed by the Texas State Board of Pharmacy. 

Read More →

Texas Pharmacists Can Now Administer Epinephrine in Emergencies

Topics: Pharmacists

Texas regulations that went into effect January 1, 2016 allow pharmacists to administer epinephrine through an auto-injector to a patient in an emergency situation.

Read More →

2016 NABP Survey of Pharmacy Law Now Available

Topics: Survey of pharmacy law

Serving as a convenient reference for individuals seeking an overview of the laws and regulations that govern pharmacy practice in 53 jurisdictions, the updated 2016 Survey of Pharmacy Law is now available.

Read More →

Lots of Baclofen API Recalled Due to Potential Contamination, FDA Warns Drug Compounders

Topics: Compounding and Fda

Certain lots of baclofen active pharmaceutical ingredient (API) manufactured by Taizhou Xinyou Pharmaceutical & Chemical Co, from the city of Taizhou in the Zhejiang Province of China, are recalled because of possible contamination with particulate matter. 

Read More →

Weight Loss Dietary Supplements Recalled Due to Undeclared Ingredients

Topics: Over the counter and Fda

BeeXtreme LLC, is recalling all lots of the weight loss dietary supplements La’Trim Plus, Oasis, and Jenesis.

Read More →

FDA Offers Webinars on Online Drug Information Resources for Students and Clinicians

Topics: Adverse drug events and Fda

FDA’s Division of Drug Information in the Center for Drug Evaluation and Research (CDER) is presenting a series of continuing education webinars targeted toward students and health care providers who wish to learn more about FDA and drug regulation.

Read More →

CDC Reports Significant Increase in Opioid Overdose Deaths

Topics: Prescription drug abuse

Prescription opioid pain relievers, such as oxycodone and hydrocodone, contribute to more overdose deaths than any other opioid type, according to new data from the Centers for Disease Control and Prevention (CDC).

Read More →

Massachusetts to Implement Updated PMP Database

Topics: Prescription monitoring program

The Massachusetts Online Prescription Monitoring Program (PMP) will be redesigned to make it easier for authorized users to submit and access PMP information.

Read More →

Bureau of Indian Affairs Naloxone Program to Be Implemented in Oklahoma

Topics: Prescription drug abuse

Oklahoma’s Bureau of Indian Affairs law enforcement officers will be provided with naloxone, the medication that can help to reverse the effects of an opioid overdose, beginning next year.

Read More →

Charleston PDAC Open to West Virginia Pharmacists

Topics: Diversion and Dea

Drug Enforcement Administration (DEA) invites West Virginia pharmacists to participate in upcoming Pharmacy Diversion Awareness Conferences in Charleston, WV.

Read More →

Fewer Teens Abusing Prescription Opioids in 2015, Monitoring the Future Survey Finds

Topics: Prescription drug abuse

Fewer teens are misusing prescription opioids, according to the 2015 Monitoring the Future Survey.

Read More →

Study Finds Link Between Twitter Content and Illicit Online Pharmacies

Topics: Prescription drug abuse

Over 45,000 Tweets promoted drug abuse over a two-week period of Tweets, indicates a study published in the Journal of Medical Internet Research.

Read More →

CDC Seeks Public Comment on Draft Guideline for Prescribing Opioids for Chronic Pain

Topics: Pain management and Cdc

The Centers for Disease Control and Prevention (CDC) is seeking public comment on the draft CDC Guideline for Prescribing Opioids for Chronic Pain, 2016. 

Read More →

Survey Provides Insight on Prescription Drug Abuse in Indiana Workplaces

Topics: Prescription drug abuse

Over 60% of Indiana employers believe misuse of prescription opioid drugs is a bigger workplace problem than use of illegal drugs, according to a survey of 200 Indiana employers conducted by the National Safety Council (NSC) and the Indiana Attorney General's Prescription Drug Abuse Prevention Task Force. 

Read More →

Weight Loss Dietary Supplement Lipo Escultura Recalled Due to Hidden Harmful Ingredients, FDA Warns

Topics: Over the counter and Fda

Lipo Escultura Corp. of Brooklyn, NY, dba JAT Productos Naturales Corp, and JAT Natural Products Corp, are voluntarily recalling the weight loss dietary supplement Lipo Escultura after a consumer illness was reported to the Food and Drug Administration (FDA).

Read More →

Legal Briefs | Theftnician

Topics: Pharmacists

Certain legal principles in civil matters hold persons or entities (such as employers) responsible for the actions of others (such as employees).

Read More →

New Law Aims to Improve Regulatory Transparency for Recently Approved Controlled Substances

Topics: Controlled substances

Signed into law by President Obama, the Improving Regulatory Transparency for New Medical Therapies Act (HR 639) amends the Controlled Substances Act (CSA) so that newly approved controlled substances are scheduled more quickly and are available sooner for health care providers to prescribe to patients. 

Read More →

FDA Alerts Health Care Providers of Recalled Compounded Multivitamins by Glades Drugs Due to High Amounts of Vitamin D3 (Cholecalciferol)

Topics: Compounding and Fda

FDA is alerting health care providers and patients of a voluntary recall of compounded multivitamin capsules containing high amounts of vitamin D3 (cholecalciferol).

Read More →

CDC Program Stresses Putting Medicines ‘Up & Away’ and Out of Sight From Children, Promotes Medication Safety

Topics: Over the counter and Cdc

During the holiday season, the Centers for Disease Control and Prevention (CDC) has partnered with PROTECT to remind consumers to keep their medicines up and away from children.

Read More →

Naloxone Nasal Spray Approved by FDA for Use in Prevention of Opioid Overdose Deaths

Topics: Prescription drug abuse and Fda

Food and Drug Administration (FDA) has approved Narcan nasal spray, a life-saving medication that can stop or reverse the effects of an opioid overdose. 

Read More →

FDA Issues Guidance for Industry Regarding Alternative Warning Language for Some OTC Drugs Containing Acetaminophen

Topics: Over the counter and Fda

In November 2015, FDA issued a guidance for industry informing manufacturers that, for certain over-the-counter (OTC) internal analgesic, antipyretic, and antirheumatic (IAAA) drug products containing acetaminophen, FDA does not object if the liver warning differs from the requirements under §201.326(a)(1)(iii)(A) and §201.326(a)(1)(v)(A) (21 Code of Federal Regulations (CFR) 201.326(a)(1)(iii)(A) and 21 CFR 201.326(a)(1)(v)(A)). 

Read More →

Internet Drug Outlets Create Public Health Threat Giving Rise to Drug-Resistant Bacteria, Indicates Report

Topics: Buying medicine online

The sale of antimicrobial drugs without a prescription by illegal Internet drug outlets negatively impacts public health by contributing to antibiotic resistance, indicates a report from the United Kingdom’s Review on Antimicrobial Resistance. 

Read More →

Prescription Drug Overdose Death Rates Drop in Oklahoma

Topics: Prescription drug abuse

In 2014, prescription drug overdose deaths in Oklahoma decreased by 5% from the previous year’s overdose death rate.

Read More →

Dietary Supplement Natureal Voluntarily Recalled by Inaffit Due to Undeclared Sibutramine

Topics: Over the counter and Fda

Inaffit, LLC, of Bethesda, MD, is voluntarily recalling all lots of Natureal light green and dark green capsules to the consumer level after Food and Drug Administration (FDA) laboratory testing confirmed Natureal contains sibutramine. 

Read More →

New Jersey Legislation Permits Substitution With Interchangeable Biological Products

Topics: Pharmacists and Prescription

In New Jersey, a bill (A2477) authorizing pharmacists filling a prescription for a biological medication to select an interchangeable biological product, was signed into law by Governor Chris Christie.

Read More →

FDA Offers Webinars on Online Drug Information Resources for Students and Clinicians

Topics: Federal regulations and Fda

FDA’s Division of Drug Information in the Center for Drug Evaluation and Research (CDER) is presenting a series of educational webinars targeted toward students and health care providers who wish to learn more about FDA and drug regulation. 

Read More →

New FDA Drug Info Rounds Training Video Available

Topics: Pharmacists and Fda

In the latest FDA Drug Info Rounds video, Antibiotic Resistance, pharmacists share tips on how to assist patients on the appropriate use of antibiotics.

Read More →

DEA Reports Controlled Substance and Heroin Abuse Spike, Increasing Drug Threat

Topics: Prescription drug abuse and Dea

Overdose deaths, particularly from prescription drugs and heroin, have reached epidemic levels, stresses Drug Enforcement Administration (DEA) in the 2015 National Drug Threat Assessment Summary.

Read More →

DEA “360 Strategy” Aims to Address Prescription Opioid Abuse, Heroin Use, and Drug Trafficking With Pilot Program in Pennsylvania

Topics: Prescription drug abuse and Dea

DEA will begin to implement a new comprehensive strategy to address prescription opioid abuse, heroin use, and related violent crime by launching a pilot program in Pittsburgh, PA.

Read More →

Sanofi US Recalls All Lots of Auvi-Q Epinephrine Injection, USP

Topics: Patient safety and Fda

Sanofi US of Bridgewater, NJ, has announced a voluntary recall of all lots of Auvi-Q® (epinephrine injection, USP) 0.15 mg and 0.3 mg strengths to the hospital, retail, and consumer level. 

Read More →

FDA Drug Compounding Podcast Provides Safety and Regulatory Perspectives

Topics: Compounding and Fda

FDA’s Center for Drug Evaluation and Research (CDER) provides a podcast series, The Director’s Corner, featuring discussions by FDA’s CDER director, Janet Woodcock, MD. 

Read More →

New FDA Drug Info Rounds Training Video Available

Topics: Pharmacists and Fda

FDA Drug Info Rounds, a series of online videos, provides important and timely drug information to practicing clinical and community pharmacists so they can help patients make better decisions.

Read More →

FDA Extends Compliance Policy Deadline for Dispensers’ Product Tracing Requirements

Topics: Federal regulations and Fda

Food and Drug Administration (FDA) has issued a guidance for industry, “DSCSA Implementation: Product Tracing Requirements for Dispensers–Compliance Policy (Revised),” announcing that it is extending a previously issued deadline for compliance with section 582 of the Federal Food, Drug, and Cosmetic Act (FD&C Act) from November 1, 2015, to March 1, 2016, because some dispensers, such as smaller, independent pharmacies and health systems, have expressed that they need additional time and are unable to comply with these requirements by November 1, 2015.

Read More →

FDA Issues Public Notifications Regarding Harmful Hidden Ingredients in Products Marketed for Weight Loss

Topics: Adverse drug events and Fda

FDA is advising consumers not to purchase or use the following products promoted for weight loss:

Read More →

FDA Advises Consumers Not to Use or Buy Certain Dietary Supplements Promoted for Sexual Enhancement Due to Hidden Drug Ingredients

Topics: Adverse drug events and Fda

FDA has issued public notifications informing consumers of dietary supplements with hidden drugs and chemicals that were identified by FDA during an examination of international mail shipments.

Read More →

NABP Meets With Leaders Around the World to Collaborate on Solutions for Protecting Consumers From Illegal Online Drug Sellers

Topics: Counterfeit drugs and Buying medicine online

Today, the National Association of Boards of Pharmacy® (NABP®) issued a report discussing the importance of international collaboration in the fight against illegal online drug sellers.

Read More →

White House Announces Plan to Address Opioid Abuse and Related Rise in Overdose Deaths

In response to the rise in deaths related to prescription opioid and heroin overdose, President Barack Obama has announced federal, state, local, and private sector efforts aimed to prevent and treat opioid addiction.

Read More →

NABP Supports Increasing Compounding Safety With Qualified Person Credentialing Program

Topics: Compounding

With the goal of increasing compounding safety, CriticalPoint, LLC, has launched the Qualified Persons Credentialing Program (QPCP) for pharmacists at entities practicing compounding under sections 503A and 503B of the Drug Quality and Security Act (DQSA), Title I – Compounding Quality Act.

Read More →

Deadline Extended for Submitting Public Comment on FDA’s Compounding Animal Drugs Draft Guidance, USP Provides Resources for Consideration

Topics: Compounding and Fda

Food and Drug Administration (FDA) seeks public comment on draft guidance regarding the compounding of animal drugs from bulk substances by pharmacies, veterinarians, and outsourcing facilities.

Read More →

Downing Labs, LLC Voluntarily Recalls All Sterile Compounded Products Due to Lack of Sterility Assurance

Topics: Compounding, Adverse drug events, and Fda

Downing Labs, LLC, of Farmers Branch, TX, has voluntarily recalled all lots of sterile products compounded and packaged by Downing Labs, and that remain within expiry, because of concerns over sterility assurance.

Read More →

Medline Industries Recalls One Lot of Acetaminophen Tablets Due to Mislabeling With Incorrect Strength

Topics: Patient safety

Medline Industries, Inc, has announced a voluntary recall of one lot of uncoated compressed acetaminophen 500 mg tablets to the consumer level.

Read More →

FDA Invites Representatives of Patient and Consumer Advocacy Groups to GDUFA Stakeholder Meetings

Topics: Patient safety and Fda

FDA is inviting representatives from patient and consumer advocacy groups to participate in periodic consultation meetings on the reauthorization of the Generic Drug User Fee Amendments of 2012.

Read More →

JAMA Study Reveals National Trends in Non-medical Prescription Opioid Use and Use Disorders

Topics: Prescription drug abuse

The number of adults who reported non-medical use of prescription opioids decreased slightly between 2003 and 2013, but the number of opioid users with a use disorder increased, indicates a new study.

Read More →

Legal Briefs | Evidence of Ebriety

Topics: Pharmacists

The issue of determining whether a licensee (or applicant) maintains the physical and mental capabilities to safely and effectively practice the profession can be a challenging undertaking by a regulatory board.

Read More →

Pre-NAPLEX Updated to Correspond to the Revised NAPLEX Competency Statements

Topics: Education and Pharmacists

The Pre-NAPLEX® content has been updated as of October 12 to correspond to the North American Pharmacist Licensure Examination® (NAPLEX®) Competency Statements that go into effect on November 1, 2015. 

Read More →

FDA Issues Guidance on Adverse Event Reporting for Outsourcing Facilities

Topics: Compounding and Fda

Food and Drug Administration (FDA) has published a guidance document, Adverse Event Reporting for Outsourcing Facilities Under Section 503B of the Federal Food, Drug, and Cosmetic Act, intended for firms registered with FDA under Section 503B of the Federal Food, Drug, and Cosmetic Act (FD&C Act) as human drug compounding outsourcing facilities. 

Read More →

FDA Announces DSCSA-Required Annual Reporting Database for Wholesale Distributor and Third-Party Logistics Providers

Topics: Patient safety and Fda

Under the Drug Supply Chain Security Act (DSCSA) of 2013, FDA is required to establish a public database to include information about wholesale distributors’ license information.

Read More →

FDA Issues Alert to Discontinue Use of Sterile Drug Products Made by Chen Shwezin Inc, dba Park Compounding Pharmacy

Topics: Compounding and Fda

FDA has issued a statement alerting health care providers and patients not to use drug products intended to be sterile that were made and distributed by Chen Shwezin Inc, dba Park Compounding Pharmacy of Westlake Village, CA, because of lack of sterility assurance.

Read More →

NABP Now Accepting Nominations for 2016 Awards to Be Presented at Annual Meeting

NABP invites you to nominate a colleague or board of pharmacy for a 2016 NABP award.

Read More →

DEA Reports Strong Turnout for 10th Prescription Drug Take-Back Day

Topics: Medication collection program disposal and Dea

Over 702,365 pounds of unneeded, unwanted, or expired prescription medications were properly disposed of as part of Drug Enforcement Administration’s (DEA) National Prescription Drug Take-Back Day Initiative on Saturday, September 26, 2015. 

Read More →

USP Publishes Notice of Intent to Revise Chapter on Sterile Compounding Preparations

Topics: Compounding

The Compounding Expert Committee of the United States Pharmacopeial Convention (USP) intends to propose revisions to General Chapter <797> Pharmaceutical Compounding—Sterile Preparations to improve clarity and reflect stakeholder input.

Read More →

Pharmacists Called to Take Action on Individual and Collective Levels by FIP President During 75th World Pharmacy Congress

Topics: Pharmacists and Pharmacy

At the opening ceremony of the 75th International Pharmaceutical Federation (FIP) World Congress of Pharmacy and Pharmaceutical Sciences, pharmacists and pharmaceutical scientists worldwide were called on by FIP President Carmen Peña to ensure the pharmacy profession remains relevant and able to respond effectively to current and future needs of the world’s communities. 

Read More →

HHS Plans to Increase Access to Naloxone and Medication-Assisted Treatment

Topics: Prescription drug abuse

In response to the increase in opioid overdose-related deaths, United States Health and Human Services (HHS) Secretary Sylvia M. Burwell announced the agency’s plan to increase access to naloxone in rural communities and expand access to medication-assisted treatment (MAT). 

Read More →

FDA Investigates the Risks of Using Tramadol in Children Aged 17 Years or Younger

Topics: Pain management and Fda

Food and Drug Administration (FDA) is investigating the use of the pain medicine tramadol in children aged 17 years and younger, because of the rare but serious risk of slowed or difficult breathing. 

Read More →

Risk of Dose Confusion and Medication Errors With Avycaz, FDA Cautions

Topics: Patient safety and Fda

Confusion about the drug strength displayed on the vial and carton labels has led to some dosing errors with the intravenous antibacterial drug AvycazTM (ceftazidime and avibactam), warns FDA.

Read More →

FIP Report Offers Case Studies on Interprofessional Education, Indicates Such Training Becoming More Common

Topics: Pharmacists

Multidisciplinary education among pharmacists, future pharmacists, and other health care providers is becoming more common as the need for collaborative practice increases, indicates a new report from the International Pharmaceutical Federation (FIP) Education Initiative.

Read More →

FDA Implements Authority to Destroy Drugs That Have Been Refused Entry Into the US

Topics: Counterfeit drugs and Fda

Food and Drug Administration (FDA) is implementing its authority to destroy a drug valued at $2,500 or less that has been refused entry into the United States under the Federal Food, Drug, and Cosmetic Act (FD&C Act). 

Read More →

One Minute Miracle, Inc Recalls All Lots of Miracle Diet 30 Capsules and Miracle Rock 48 Capsules Due to Undeclared Drug Products

Topics: Over the counter and Fda

The One Minute Miracle, Inc, is voluntarily recalling all lots of Miracle Diet 30 capsules and Miracle Rock 48 capsules to the consumer level.

Read More →

CDC Commits $20 Million to Advance Prevention of Prescription Drug Overdoses With New Program

Topics: Prescription drug abuse and Cdc

With the goal of ending the prescription drug overdose epidemic, the Centers for Disease Control and Prevention (CDC) is committing $20 million to launch Prescription Drug Overdose: Prevention for States, a new program that will support efforts in 16 states. 

Read More →

Prescription Drug Use Levels Remain Constant in 2014, SAMHSA Reports

Topics: Prescription drug abuse

According to the 2014 National Survey on Drug Use and Health (NSDUH) (PDF), the number of people abusing prescription medications in the last 30 days was 6.5 million, which is similar to 2013 levels. 

Read More →

FDA Updates Warning on Compounded or Repackaged Drugs Stored in Becton-Dickinson Syringes to Include Additional Syringe Sizes

Topics: Compounding and Fda

Food and Drug Administration (FDA) is expanding its alert regarding compounded or repackaged drugs stored in Becton-Dickinson (BD) general use syringes to include certain additional syringe sizes including 1 mL, 10 mL, 20 mL, and 30 mL BD syringes, and BD oral syringes.

Read More →

MediStat RX Recalls Sterile Drug Products Due to Possible Contamination

Topics: Compounding and Fda

MediStat Pharmacy, a 503B outsourcing facility in Foley, AL, has initiated a national recall of all sterile injectable products distributed between November 1, 2014, and September 3, 2015.

Read More →

FDA Releases Draft Guidance on Naming System for Biological Products, Seeks Public Comment

Topics: Fda

To ensure the safe use of biological products, Food and Drug Administration (FDA) has developed draft guidance for industry on the nonproprietary naming of biological products.

Read More →

Web Search Engine to Warn About Fake Online Pharmacies

Topics: Counterfeit drugs and Buying medicine online

To help consumers avoid potentially unsafe online drug outlets, Bing will provide a new warning message on certain search results in Bing.com.

Read More →

New Drug Technologies Promise to Support Patient Safety

Topics: Patient safety

Three-dimensional printing (3DP) technology is being used to create a pill that delivers an optimal dose and is easier for patients to consume. 

Read More →

Updated Model Act Now Available to Assist Boards of Pharmacy in Developing Laws and Rules to Protect Public Health

Topics: Pharmacies and Pharmacists

The recently amended Model State Pharmacy Act and Model Rules of the National Association of Boards of Pharmacy (Model Act) is now available to provide the state boards of pharmacy with model language that may be used for developing state laws or board rules in their efforts to protect public health.

Read More →

Most College Students Misusing Prescription Drugs Begin Non-medical Use in Winter Months

Topics: Prescription drug abuse

Winter is the peak season for full-time college students to start non-medical use of prescription drugs, such as pain relievers and stimulants, indicates a new study by the Substance Abuse and Mental Health Services Administration.

Read More →

Join Fellow Pharmacists and Take the Pledge to Fight Prescription Drug Abuse

Topics: Pharmacists and Prescription drug abuse

Pharmacists are encouraged to take the “Pharmacist’s Pledge to Make a Difference” in the battle against prescription drug abuse. 

Read More →

Legal Briefs | Preemption: The Maine Reason Canadian Importations Put on Ice

Topics: Buying medicine online

The legal issues surrounding the introduction of foreign prescription drugs into the United States market are complex and subject to the application of at least the federal and state laws.

Read More →

Efforts to Fight Prescription Opioid Abuse Part of New White House Heroin Response Strategy

Topics: Prescription drug abuse

The White House Office of National Drug Control Policy (ONDCP) announced funding for the new Heroin Response Strategy that will address the heroin and prescription opioid epidemic as both a public health and a public safety issue.

Read More →

FDA Warns Health Care Providers Not to Use Compounded Drugs Stored in Becton-Dickinson (BD) 3 mL and 5 mL Syringes

Topics: Compounding and Fda

Food and Drug Administration (FDA) has released a warning to health care providers not to administer to patients compounded or repackaged drugs that have been stored in 3 mL and 5 mL syringes manufactured by Becton-Dickinson (BD) unless there is no suitable alternative available.

Read More →

Hartley Medical Voluntarily Recalls Prolotherapy With Phenol Due to Nonsterility Concerns

Topics: Compounding and Fda

Hartley Medical is voluntarily recalling three lots of prolotherapy with phenol (injectable) due to nonsterility concerns.

Read More →

Merck Recalls TEMODAR® and Temozolomide Bottles With Cracked Child-Proof Caps

Topics: Patient safety

Merck, in conjunction with Consumer Product Safety Commission (CPSC), is recalling TEMODAR® and temozolomide bottles with cracks in the child-resistant caps.

Read More →

Canadian Online Drug Seller, Pharmacist Employed by PharmacyChecker Under Fire From US Authorities

Topics: Counterfeit drugs and Buying medicine online

A United States district court in Montana indicted Canada Drugs last week with charges related to the selling of $78 million worth of unapproved, mislabeled, and counterfeit drugs to US doctors over three years.

Read More →

Legislation Aimed at Curbing Drug Abuse Among Seniors Introduced to US Senate

Topics: Prescription drug abuse

Seniors who receive Medicare and have a history of opioid abuse would be restricted to one pharmacy and one doctor under proposed legislation intended to help them recover from addiction. 

Read More →

FDA Guide Gives Parents, Caregivers Vaccine Information

Topics: Vaccinations and Fda

Coinciding with the start of many school calendars, Food and Drug Administration (FDA) has released a guide for parents and caregivers on vaccinating children. 

Read More →

Rx Response Renamed Healthcare Ready, Works With Regulators to Strengthen Health Care Networks

Topics: Patient safety

Rx Response, the organization that helps communities provide medications to patients during disasters, has changed its name to Healthcare Ready.

Read More →

Maryland Goes Live With NABP PMP InterConnect; 30 States Now Sharing PMP Data

Topics: Prescription monitoring program

The Maryland Prescription Drug Monitoring Program has deployed NABP PMP InterConnect®, bringing the total number of live participating state prescription monitoring programs (PMPs) to 30.

Read More →

Pharmacists Help Hypertension Patients Lower Blood Pressure, Study Finds

Topics: Pharmacists

When medical care teams include pharmacists, hypertension patients fare better, suggests a new study. 

Read More →

Maine Pharmacy Personnel Invited to DEA Diversion Prevention Conference

Topics: Controlled substances, Diversion, and Dea

Drug Enforcement Administration (DEA) is offering two regional one-day Pharmacy Diversion Awareness Conferences (PDAC) in South Portland, ME.

Read More →

Legal Briefs: Court Extracts Teeth From Dental Board Ruling

Topics: Federal regulations

On February 25, 2015, the United States Supreme Court ruled on an important case relevant to the regulatory community and the antitrust protections afforded to state regulatory boards.

Read More →

NABP Stresses Need for Accountability in Enforcing Internet Policies to Protect the Public From Illegal Online Drug Sellers

Topics: Counterfeit drugs and Buying medicine online

Last week, NABP issued a report urging greater accountability by the stakeholders charged with ensuring that action is taken against websites illegally selling medications online.

Read More →

VPP Online Application Launches, Offers Streamlined Process

Topics: Pharmacies

To further streamline Verified Pharmacy ProgramTM (VPPTM) processes, the VPP online customer application was launched on July 15, 2015. 

Read More →

DEA Prescription Drug Take-Back Day to Be Held September 12 for Pennsylvania and Delaware

As part of the Drug Enforcement Administration (DEA) National Prescription Drug Take-Back day effort, Take-Back day for the states of Pennsylvania and Delaware will be held on Saturday, September 12, 2015. 

Read More →

Task Force of Physicians Encourages Use of PMPs to Help Protect Patients From Prescription Drug Abuse

Topics: Prescription drug abuse and Prescription monitoring program

In response to the prescription opioid abuse epidemic, a task force of physician groups is urging physicians to register for and use prescription monitoring programs (PMPs) as part of the decision-making process when considering treatment options.

Read More →

NABP Stresses Need for Accountability in Enforcing Internet Policies to Protect the Public From Illegal Online Drug Sellers

Topics: Counterfeit drugs and Internet pharmacy

Today, NABP issued a report urging greater accountability by the stakeholders charged with ensuring that action is taken against websites illegally selling medications online. As detailed in the Internet Drug Outlet Identification Program Progress Report for State and Federal Regulators: July 2015, thousands of websites illegally distribute medications and avoid retribution. Such sites often distribute dangerous counterfeit drugs, putting at risk the health of the consumers who use them. Many of these rogue sites use domain names obtained from a small number of registrars who turn a blind eye to their illegal activity. The report highlights the need for the Internet Corporation for Assigned Names and Numbers (ICANN) and domain name registrars – the stakeholders responsible for facilitating the use of Internet domain names – to enforce policies forbidding illegal use of websites and to take more accountability for shutting down rogue sites. 

Read More →

DEA to Hold 10th Prescription Drug Take-Back Day This September

Topics: Diversion, Prescription drug abuse, and Dea

To help the fight against prescription drug abuse and diversion, Drug Enforcement Administration (DEA) has announced that it will bring back the National Prescription Drug Take-Back Day event.

Read More →

Ohio Pharmacists Can Now Dispense Naloxone Without a Prescription

Topics: Prescription drug abuse

Ohio pharmacists are among the latest in the country to be allowed to dispense naloxone, a drug that reverses opioid overdose, without a prescription.

Read More →

New Jersey Law Toughens State PMP Requirements for Pharmacists

Topics: Controlled substances and Prescription monitoring program

New Jersey Governor Chris Christie recently signed into law a bill that will require prescribers and pharmacists to register for the state’s prescription monitoring program (PMP) and to check the database that tracks controlled substance (CS) prescriptions under certain situations.

Read More →

Online Drug Company Returns Profits Made From Illegal Prescription Sales

Topics: Internet pharmacy

An online prescription drug seller has agreed to forfeit $450,000 in illegal sales after knowingly dispensing medication without a prescription.

Read More →

FDA Warns Against Unapproved Prescription Ear Drops

Topics: Fda

Food and Drug Administration (FDA) has ordered the manufacturers of certain prescription ear drops to stop making and distributing the products because they are not FDA-approved.

Read More →

Reading Medicine Labels Helps Reduce Acetaminophen Overdose, Advises Coalition

Topics: Education and Over the counter

With half of all acetaminophen overdoses being unintentional, the Acetaminophen Awareness Coalition reminds pharmacists and other health care providers to encourage patients to properly read medicine labels.

Read More →

California, Oregon to Allow Pharmacists to Dispense Birth Control Under New Rules

Topics: Over the counter

California and Oregon will soon become the only two states in the country where patients can obtain hormonal contraceptives directly from pharmacists without a prescription.

Read More →

Virginia Board Helps Drones Make Special Delivery for Health Fair Attendees

Topics: Pharmacists

Some Virginia residents attending a free health fair last week received a special delivery – their medications came via drone.

Read More →

Pharmacy Stakeholders Worldwide Invited to Help Shape Practice During FIP 2015 Congress

Topics: Pharmacy

Practitioners, researchers, and academics worldwide are invited to help shape modern pharmacy practice during the 75th International Pharmaceutical Federation (FIP) World Congress of Pharmacy and Pharmaceutical Sciences 2015. 

Read More →

FDA Expands NSAID Warning Labels Regarding Risks of Heart Attack, Stroke

Topics: Over the counter and Fda

The labels of certain non-steroidal anti-inflammatory drugs (NSAIDs) will soon contain more detailed information about the risk that the drugs may contribute to heart attack and stroke, reports Food and Drug Administration (FDA). 

Read More →

Colorado Allows Pharmacies to Dispense Naloxone Without a Prescription as Overdose Deaths Climb

Topics: Prescription drug abuse and Addiction recovery

Coming at a time when heroin and opioid overdoses are gripping the nation, a new Colorado law allows pharmacies to sell naloxone without a prescription.

Read More →

New Jersey’s Acino Products Ordered to Stop Selling Rectacort-HC and GRx HiCort 25

Topics: Fda

Under the direction of FDA, a federal judge for the District of New Jersey has ordered Acino Products, LLC, of Hamilton, NJ, to stop selling and destroy certain unapproved and misbranded prescription drugs in their possession.

Read More →

Prescription Opioid Abuse Key Indicator for Future Heroin Abuse

Topics: Prescription drug abuse and Cdc

People who abuse prescription opioid painkillers are 40 times more likely to abuse heroin, reports the July edition of CDC Vital Signs. 

Read More →

Dispensers Get Four More Months to Meet DSCSA Provisions

Topics: Counterfeit drugs, Diversion, and Fda

Food and Drug Administration (FDA) has granted dispensers an additional four months to comply with provisions of the Drug Supply Chain Security Act (DSCSA) that call for tracking and tracing drug packages across the drug supply chain. 

Read More →

Pharmacy Robberies Still Climbing in Some States, Reports Drug Topics

Topics: Pharmacy and Dea

During the first five months of 2015, Indiana has had 68 pharmacy robberies, the most out of any other state, reports Drug Topics. 

Read More →

More Than 26,000 Overdoses Reversed by Laypersons Administering Naloxone, CDC Reports

Topics: Prescription drug abuse and Cdc

From 1996 through June 2014, organizations surveyed by the Centers for Disease Control and Prevention (CDC) have provided more than 150,000 overdose reversal kits containing naloxone to laypersons who have reported 26,463 overdose reversals in that time. 

Read More →

Daytrana Patch May Cause Permanent Skin Color Changes, FDA Warns

Topics: Fda

Food and Drug Administration (FDA) is warning health care providers and consumers that Daytrana®, a methylphenidate transdermal system prescribed for treating attention deficit hyperactivity disorder may cause permanent loss of skin color in the affected area. 

Read More →

Pennsylvania Governor Signs Law Allowing Pharmacists to Issue Flu Vaccinations to Some Children

Topics: Pharmacists and Vaccinations

Pennsylvania Governor Tom Wolf has signed into law a bill that will allow pharmacists to provide flu vaccinations to people age nine or older.

Read More →

Physician Charged With Illegally Distributing Pain Medications Resulting in Five Fatalities, DEA Reports

Topics: Controlled substances and Diversion

Jaime Guerrero, a former medical physician with offices in Louisville, KY, and Jeffersonville, IN, has been indicted for knowingly distributing and dispensing Schedule II and III controlled substances to patients without a legitimate medical purpose.

Read More →

FDA Takes Action Against More Than 1,050 Websites Selling Counterfeit Prescription Drugs and Medical Devices

Topics: Buying medicine online, Diversion, and Fda

As part of the eighth annual International Internet Week of Action (IIWA), Food and Drug Administration (FDA), in collaboration with international regulatory and law enforcement agencies, took action against more than 1,050 websites that illegally sell potentially dangerous, unapproved prescription medicines and medical devices to consumers. 

Read More →

Drug Overdoses Doubled Over the Last 14 Years, Half Are Related to Prescription Drugs, Indicates New Report

Topics: Prescription drug abuse

Drug overdoses are now the leading cause of injury deaths in the United States, and half of those injuries, 22,000 per year, are related to prescription drugs, according to a new report from the Trust for America’s Health and the Robert Wood Johnson Foundation.

Read More →

Illinois Pilot Program Would Require Certain Hydrocodone Products to be Dispensed With Locking Mechanisms

Topics: Controlled substances

Illinois lawmakers have approved a pilot program that would add locking devices on some prescription painkiller prescriptions to ensure only the patient has access to the medication. 

Read More →

New Resource for Consumers to Identify Safe Online Pharmacies Promoted by NABP Executive Director

Topics: Counterfeit drugs and Buying medicine online

NABP Executive Director Carmen A. Catizone, MS, RPh, DPh, and Libby Baney, JD, executive director of the Alliance for Safe Online Pharmacies participated in a series of interviews to spread awareness about .pharmacy as a resource for consumers.

Read More →

FDA Issues Draft Guidance on Compounding of Animal Drugs from Bulk Substances

Topics: Compounding and Fda

Food and Drug Administration (FDA) has released a draft guidance document related to the compounding of animal drugs from bulk substances.

Read More →

Proposed Federal Legislation Would Permit Office Use Compounding, Revise MOUs in Section 503A of FD&C Act

Topics: Compounding

Legislation proposed by Senator David Vitter (R-LA) would revise Section 503A of the FD&C Act to exempt drug products where the pharmacy’s product is “compounded and distributed to a practitioner where, as permitted under State law, the drug product is used in the treatment of or administered to a patient of the practitioner.” 

Read More →

Mylan Expands Recall of Certain Injectable Products Due to Particulate Matter

Topics: Compounding and Fda

Mylan N.V., of Hertfordshire, England and Pittsburgh, PA, has expanded an earlier recall to the hospital/user level of certain lots of injectable products, including gemcitabine and methotrexate, due to the presence of visible particulate matter observed during testing of retention samples. 

Read More →

Don’t Buy Drugs From Overseas on the Internet, Consumer Reports Advises

Topics: Buying medicine online

Although Internet shopping can lead to more options and better deals for things like electronics and small appliances, consumers should never use the Internet to purchase medications from overseas, a new report from Consumer Reports advises. 

Read More →

New York State Senate Passes Bill Intended to Prevent Prescription Drugs From Entering the Black Market

Topics: Prescription drug abuse

The New York State Senate has passed a bill that would establish criminal charges for the theft and unauthorized possession of blank official New York State prescription forms.

Read More →

Consumers Should Dispose of Unused Medications to Prevent Theft and Accidental Ingestion, FDA Advises

Topics: Medication collection program disposal and Fda

Consumers and caregivers should remove expired, unwanted, or unused medicines from their homes as quickly as possible to reduce the chance that the drugs may be stolen or accidentally ingested, Food and Drug Administration (FDA) warns. 

Read More →

Misuse of ADHD Drugs Most Likely to Start in Older Teens, Study Indicates

Topics: Controlled substances and Prescription drug abuse

Teenagers between the ages of 16 and 19 are at the highest risk for misuse of prescription stimulants and females are more likely than males to misuse the drugs.

Read More →

FDA Extends Comment Period for Compounding-Related MOU

Topics: Compounding and Fda

Food and Drug Administration (FDA) is extending the deadline to submit comments regarding a compounding-related memorandum of understanding (MOU) draft that appeared in the Federal Register on February 19, 2015.

Read More →

FDA Committee to Consider Compounding Restrictions on Acetaminophen, Three Other Drugs

Topics: Compounding and Fda

The Pharmacy Compounding Advisory Committee of FDA will hold a public meeting that will include discussions regarding revisions to the list of drug products that may not be compounded under the exemptions provided by the Federal Food, Drug, and Cosmetic Act. 

Read More →

HHS Announces New Interactive Training on Safe Opioid Use

Topics: Pain management

The Department of Health and Human Services (HHS) has announced a new, interactive training course that teaches health care providers how to talk to patients about safely using opioids to manage chronic pain.

Read More →

New Synthetic Drug Linked to 18 Deaths in Single Florida County, The New York Times Reports

Topics: Prescription drug abuse

A dangerous synthetic drug known as Flakka may be responsible for 18 recent deaths in Broward County, FL. 

Read More →

General Availability for .Pharmacy Domain Names Begins June 3, 2015

Topics: Buying medicine online

NABP is pleased to announce that general availability for the .pharmacy domain begins June 3, 2015.

Read More →

DEA Operation Spans Four States, Leads to 280 Arrests Related to Prescription Drug Diversion and Abuse

Topics: Counterfeit drugs and Dea

Drug Enforcement Administration (DEA), in collaboration with federal prosecutors, has announced the conclusion of a 15-month operation that resulted in 280 arrests across four states, including arrests of 22 doctors and pharmacists.

Read More →

FDA Submits Proposal to Collect Information Regarding the Impact of Physical Differences in Generic Drug Pills on Medication Adherence

Topics: Medication errors and Fda

Food and Drug Administration (FDA) has proposed a series of surveys to gather information on patient awareness about changes in the appearance of their medications, how often the change in appearance occurs, and what strategies pharmacists use to inform patients when these changes occur. 

Read More →

Counterfeit Medications, Illegal Online Drug Sellers Targeted by New Consumer Education Campaign

Topics: Buying medicine online

The Alliance for Safe Online Pharmacies (ASOP) has created a new campaign, “Buy Safe Rx,” to increase awareness of the potentially life-threatening risks associated with buying prescription medications online and to provide consumers with the information they need to protect themselves.

Read More →

General Availability for .Pharmacy Domain Names Begins June 3, 2015

Topics: Buying medicine online

The National Association of Boards of Pharmacy® (NABP®) is pleased to announce that general availability for the .pharmacy domain begins June 3, 2015. At this time, all pharmacies and pharmacy-related entities may apply for .pharmacy domain names.

Read More →

NABP 2015-2016 Executive Committee Inaugurated at 111th Annual Meeting in New Orleans, LA

Delegates to the NABP 111th Annual Meeting, held May 16–19, 2015, in New Orleans, LA, elected individuals to fill the president-elect, treasurer, and open member positions on the Association’s 2015-2016 Executive Committee. 

Read More →

NABP Honors Leaders at the Forefront of Public Health Protection at Association’s 111th Annual Meeting

NABP honored leaders in the protection of public health at the Association’s 111th Annual Meeting, held May 16-19, 2015, in New Orleans, LA.

Read More →

June DEA Conference on Preventing Drug Diversion Open to Pharmacy Personnel in Oklahoma

Topics: Controlled substances and Dea

Drug Enforcement Administration (DEA) is offering two regional one-day Pharmacy Diversion Awareness Conferences (PDAC) in Oklahoma City, OK, with one on Saturday, June 27, 2015, and another on Sunday, June 28, 2015. 

Read More →

Legal Briefs: Serve You ‘Served Up’ Discipline

Topics: Federal regulations

Boards of pharmacy are statutorily created and empowered to protect the public through enforcement of the laws. One might question how far such authority extends.

Read More →

NABP 2015-2016 Executive Committee Inaugurated at 111th Annual Meeting in New Orleans, LA

Delegates to the National Association of Boards of Pharmacy® (NABP®) 111th Annual Meeting, held May 16-19, 2015, in New Orleans, LA, elected individuals to fill the president-elect, treasurer, and open member positions on the Association’s 2015-2016 Executive Committee.

Read More →

Delegates Approve Nine Resolutions at the NABP 111th Annual Meeting

Delegates from the member boards of pharmacy adopted nine resolutions during the National Association of Boards of Pharmacy® (NABP®) 111th Annual Meeting, held May 16-19, 2015, in New Orleans, LA. 

Read More →

Joseph L. Adams, RPh, Assumes Chair of NABP 2015-2016 Executive Committee, Receives President’s Award

Joseph L. Adams, RPh, immediate past president of the National Association of Boards of Pharmacy® (NABP®), assumed the office of chairperson of the Association’s 2015-2016 Executive Committee during the Final Business Session of the NABP 111th Annual Meeting, held May 16-19, 2015, in New Orleans, LA.

Read More →

Edward G. McGinley, MBA, RPh, Begins Term as NABP President During the Association’s 111th Annual Meeting

Edward G. McGinley, MBA, RPh, began his term as president of the National Association of Boards of Pharmacy® (NABP®) during the Final Business Session of the Association’s 111th Annual Meeting, May 16-19, 2015, in New Orleans, LA.

Read More →

Hal Wand, MBA, RPh, Elected NABP President-elect at Association’s 111th Annual Meeting

Hal Wand, MBA, RPh, was elected to serve as the 2015-2016 president-elect of the National Association of Boards of Pharmacy® (NABP®) during the Association’s 111th Annual Meeting, May 16-19, 2015, in New Orleans, LA.

Read More →

Jeanne D. Waggener, RPh, Elected NABP Treasurer at Association’s 111th Annual Meeting

Jeanne D. Waggener, RPh, was elected to serve as the 2015-2016 treasurer of the National Association of Boards of Pharmacy® (NABP®) during the Association’s 111th Annual Meeting, May 16-19, 2015, in New Orleans, LA.

Read More →

John A. Foust, PharmD, DPh, Elected to Serve as Member of Executive Committee at NABP 111th Annual Meeting

John A. Foust, PharmD, DPh, was elected to serve a three-year member term, representing District 6, on the Executive Committee of the National Association of Boards of Pharmacy® (NABP®) during the Association’s 111th Annual Meeting, May 16-19, 2015, in New Orleans, LA.

Read More →

Mark D. Johnston, RPh, Re-Elected to Serve as Member of NABP Executive Committee at Association’s 111th Annual Meeting

Mark D. Johnston, RPh, was re-elected to serve a second three-year member term, representing District 7, on the Executive Committee of the National Association of Boards of Pharmacy® (NABP®) during the Association’s 111th Annual Meeting, May 16-19, 2015, in New Orleans, LA.

Read More →

NABP Executive Committee Names 2015 Honorary President Michael A. Podgurski, RPh

Each year the National Association of Boards of Pharmacy® (NABP®) Executive Committee selects an individual to serve as its honorary president for the coming year. NABP is pleased to announce that Michael A. Podgurski, RPh, has been awarded this honor.

Read More →

Rogue Internet Drug Sellers Scrutinized at Congressional Committee Hearing on Internet Accountability

Topics: Counterfeit drugs and Buying medicine online

The United States House of Representatives Judiciary Subcommittee on Courts, Intellectual Property, and the Internet held a hearing today, May 13, 2015, to hear testimony from stakeholders regarding the Internet Corporation for Assigned Names and Numbers, how the Internet is governed, and steps for trust and accountability in the Internet’s operation. 

Read More →

‘Good Samaritan’ Act Signed in Nevada, Extends Naloxone Access and Dispensing

Topics: Prescription drug abuse

Nevada Governor Brian Sandoval has signed a new law that will reduce potential criminal penalties for people who report drug overdoses, and expand access to naloxone, the medication that can help to reverse the effects of an opioid overdose.

Read More →

Medical Marijuana Bill Approved by Louisiana Senate, Now Heads to House

Topics: Medical marijuana

The Louisiana State Senate voted 22 to 13 to approve medical marijuana legislation that would allow the state to develop a legal distribution system for medical marijuana, with the exclusion of forms of the drug that are smoked or inhaled.

Read More →

Iowa Senate Passes Bill to Address Sale of Synthetic Drugs, Reclassify Marijuana as Schedule II

Topics: Controlled substances and Medical marijuana

The Iowa Senate has approved a bill that ensures penalties for selling synthetic drugs are in line with penalties for selling other controlled substances (CS), and an amendment to the bill has now tied it to the state’s medical marijuana policy.

Read More →

Four Products Marketed as Weight Loss Supplements Contain Hidden Ingredients, FDA Warns

Topics: Over the counter and Fda

Food and Drug Administration (FDA) has posted warnings regarding four products marketed as dietary supplements for weight loss that contain hidden drug ingredients.

Read More →

Consumer Education, Awareness Key to Combating Rogue Online Drug Sellers

Topics: Counterfeit drugs and Buying medicine online

Yesterday, the National Association of Boards of Pharmacy® (NABP®) issued a report that profiles the continued pervasiveness of illegal online drug seller activity and the need for increased awareness about the risks such activity presents to public health.

Read More →

Outbreak of HIV and HCV Infections in Indiana Prompts CDC Health Alert

Topics: Prescription drug abuse and Cdc

Centers for Disease Control and Prevention (CDC) has issued an official health advisory alerting health care providers to an outbreak of human immunodeficiency virus (HIV) and hepatitis C (HCV) among persons who inject drugs in a rural portion of Indiana. 

Read More →

Synthetic Cannabinoid Hospitalizations Surge in Alabama, Mississippi, and Other States

Topics: Drug poisoning

From March 15 through April 20, 462 people in Alabama were sent to a hospital emergency department, and 473 people in Mississippi were hospitalized due to synthetic cannabinoid overdoses.

Read More →

Multiple Lots of Mucinex Cold, Sinus, and Flu Medications Recalled Due to Possible Labeling Error

Topics: Over the counter and Fda

RB (formerly Reckitt Benckiser) of Parsippany, NJ, has issued a voluntary recall of certain lots of liquid Mucinex® due to a potential error involving the over-the-counter medications’ drug facts label. 

Read More →

ADHD Stimulant Abuse Growing Among US Workers, The New York Times Reports

Topics: Prescription drug abuse

Though commonly associated with college students, abuse of prescription stimulants intended to treat attention deficit hyperactivity disorder (ADHD) is a growing phenomenon among American workers.

Read More →

Opioid Dispensing and Prescription Overdose Decreased Substantially After Introduction of Abuse-Deterrent Formulation, Study Reports

Topics: Prescription drug abuse

Overdoses and overall prevalence of opioid prescription painkillers has decreased since abuse-deterrent extended-release oxycodone hydrochloride was introduced and propoxyphene was withdrawn from the United States market.

Read More →

Counterfeit Botox Found in the United States, FDA Warns

Topics: Counterfeit drugs and Fda

Food and Drug Administration (FDA) is alerting health care providers that a counterfeit version of Botox® has been found in the United States, and may have been sold to doctors’ offices and clinics throughout the country.

Read More →

Flurbiprofen-Containing Topical Medication May Be Dangerous to Pets, Cautions FDA

Topics: Adverse drug events and Fda

People who use topical medications containing flurbiprofen, a nonsteroidal anti-inflammatory drug (NSAID), should take care to prevent their pets from being exposed to the drug, recommends FDA in a Safety Alert. 

Read More →

FDA Alerts Consumers About Dangerous Synthetic Steroids Present in Product Marketed as Supplement

Topics: Over the counter and Fda

Tri-Methyl Xtreme, a product marketed as a dietary supplement for muscle growth contains anabolic steroids and should not be used, FDA is warning consumers. 

Read More →

Nearly One in Four Narcotic Painkillers Are Misused, Research Indicates

Topics: Prescription drug abuse and Pain management

An estimated 25% of narcotic painkillers prescribed for chronic pain are misused, and up to 12% of people prescribed such drugs struggle with addiction.

Read More →

Consumers Urged to Protect Themselves When Shopping for Prescription Medication Online

Topics: Counterfeit drugs and Buying medicine online

The Partnership for Safe Medicines is urging consumers to protect themselves from substandard, dangerous, and counterfeit drugs by checking that online pharmacies are accredited by NABP’s Verified Internet Pharmacy Practice Sites® (VIPPS®) or Veterinary-Verified Internet Pharmacy Practice Sites® (Vet-VIPPS®) programs.

Read More →

FDA Reveals New Guidance for Abuse-Deterrent Opioid Development

Topics: Prescription drug abuse and Fda

Food and Drug Administration (FDA) has issued final guidance for manufacturers on the development and labeling of abuse-deterrent opioids.

Read More →

Metric System Best for Dosing Liquid Medicine, Say Pediatricians

Topics: Over the counter

American Academy of Pediatrics (AAP) recommends that parents and health care providers use only metric units when giving children liquid medicine.

Read More →

Canadian Online Pharmacy Subject of Further FDA, Canadian Scrutiny

Topics: Counterfeit drugs, Buying medicine online, and Fda

The Royal Canadian Mounted Police (RCMP) raided the headquarters of CanadaDrugs.com last week, Canada’s largest online pharmacy and the subject of past US FDA investigations. 

Read More →

HHS Announces New Initiative to Reduce Opioid Dependence and Overdose Trends

Topics: Prescription drug abuse

The United States Department of Health and Human Services (HHS) plans to take a three-pronged approach to tackling opioid abuse and related deaths in 2016.

Read More →

FDA Warns About Homeopathic Asthma Treatments, Considers Regulating Homeopathic Products

Topics: Over the counter and Fda

Homeopathic over-the-counter asthma treatments have not been evaluated by Food and Drug Administration (FDA) for safety or effectiveness, warns the agency in a recent public safety alert. 

Read More →

Teens and Toddlers at Great Risk of Accidental Medication Poisoning, Study Finds

Topics: Medication errors

Toddlers and teens are at the most risk of experiencing accidental medication poisoning, reports a new study from Safe Kids Worldwide and the American Association of Poison Control Centers.

Read More →

Still Time to Take the Survey on MPJE Competency Statements; Boards of Pharmacy Staff Encouraged to Participate

Topics: Pharmacy

Executive officers and boards of pharmacy staff are encouraged to participate in an online survey regarding the Multistate Pharmacy Jurisprudence Examination® (MPJE®) competency statements.

Read More →

All Dispensing Pharmacies Eligible to Request .Pharmacy Domain Names Beginning April 1, 2015

Topics: Internet pharmacy

NABP will begin accepting applications for .pharmacy domain names from all dispensing pharmacies beginning April 1, 2015. 

Read More →

DEA Issues Warning Against Potent Opioid Painkiller

Topics: Controlled substances and Dea

Drug Enforcement Administration (DEA) has issued a nationwide alert concerning the use of fentanyl, a potent Schedule II medication used as an anesthetic and analgesic. 

Read More →

Congress Considering Legislation to Reschedule Marijuana

Topics: Controlled substances and Medical marijuana

A bipartisan group of senators has introduced the Compassionate Access, Research Expansion, and Respect States Act (S 683), which would reclassify marijuana as a Schedule II controlled substance. 

Read More →

Approximately 93% of China’s Internet Pharmacy Market is Operating Illegally, ASOP Report Indicates

Topics: Counterfeit drugs and Buying medicine online

About 93% of websites selling medications to consumers in China were found to be either “rogue” or “unapproved” pharmacies that were not compliant with applicable Chinese laws and regulations.

Read More →

All Dispensing Pharmacies Eligible to Request .Pharmacy Domain Names Beginning April 1, 2015

Topics: Buying medicine online

The National Association of Boards of Pharmacy® (NABP®) will begin accepting applications for .pharmacy domain names from all dispensing pharmacies beginning April 1, 2015.

Read More →

Timely Pharmacy Regulation Topics Offer Attendees Chance to Earn Up to Eight Contact Hours of CPE Credit at the NABP 111th Annual Meeting

Topics: Continuing education

The National Association of Boards of Pharmacy® (NABP®) is offering attendees the opportunity to earn up to eight contact hours (0.8 CEUs) of Accreditation Council for Pharmacy Education-accredited continuing pharmacy education (CPE) credit at its 111th Annual Meeting themed “Boards of Pharmacy and NABP – Marching In Together and Stronger.”

Read More →

NABP, Stakeholders Release Consensus Document on the Challenges and ‘Red Flag’ Warning Signs Related to Prescribing and Dispensing Controlled Substances

Topics: Controlled substances and Prescribing authority

A coalition of stakeholder organizations released a consensus document representing the medical, pharmacist, and supply chain spectrum highlighting the challenges and ‘red flag’ warning signs related to prescribing and dispensing controlled substance (CS) prescriptions.

Read More →

Boards of Pharmacy Staff Encouraged to Participate in Survey on MPJE Competency Statements

Topics: Education and Pharmacists

Executive officers and boards of pharmacy staff are encouraged to participate in an online survey regarding the Multistate Pharmacy Jurisprudence Examination® (MPJE®) competency statements. 

Read More →

Hospira Recalls One Lot of Lactated Ringer's Irrigation Due to Mold Contamination

Topics: Compounding and Fda

Hospira, Inc, of Lake Forest, IL, has initiated a voluntary recall of one lot of lactated Ringer’s irrigation, 3000 mL (National Drug Code 0409-7828-08) to the user level due to a customer report of particulate matter confirmed to be Aspergillus kanagawaensis, a non-toxic mold.

Read More →

New FDA Drug Info Rounds Training Video Available

Topics: Pharmacists and Fda

In the latest Drug Info Rounds video, pharmacists demonstrate how to use the NDC Directory.

Read More →

NABP, Stakeholders Release Consensus Document on the Challenges and “Red Flag” Warning Signs Related to Prescribing and Dispensing Controlled Substances

Topics: Controlled substances, Pharmacists, and Prescription drug abuse

A coalition of stakeholder organizations released a consensus document representing the medical, pharmacist, and supply chain spectrum highlighting the challenges and “red flag” warning signs related to prescribing and dispensing controlled substance prescriptions. 

Read More →

FDA Approves First Biosimilar in US, Expects Other Biosimilars to Be Approved Soon

Topics: Fda

Food and Drug Administration (FDA) has approved Zarxio® (filgrastim-sndz) as a biosimilar to Neupogen for the same five indications for which United States-licensed Neupogen® is approved.

Read More →

FDA Issues Notifications Regarding 36 Supplements Marketed as Natural but Containing Hidden Drugs

Topics: Over the counter and Fda

FDA has posted public notifications regarding 36 products, frequently marketed as natural supplements, warning the products contain hidden drug ingredients such as sildenafil, fluoxetine, and sibutramine. 

Read More →

FDA Launches Mobile Application to Provide Information About Drug Shortages

Topics: Fda

FDA has launched the agency’s first mobile application specifically designed to improve access to information about drug shortages. 

Read More →

ASOP and FSMB Release Free Continuing Education Program for Pharmacists and Physicians

Topics: Buying medicine online and Pharmacists

A free online continuing education program (CME/CPE), entitled “Internet Drug Sellers: What Providers Need to Know” is now available for pharmacists and physicians.

Read More →

Heritage Pharmaceuticals Recalls 13 Lots of Injectable Medications Citing Lack of Sterility Assurance

Topics: Compounding

Heritage Pharmaceuticals of Eatontown, NJ, has issued a voluntary recall of 13 lots of injectable medications due to a lack of sterility assurance. 

Read More →

Global Police Group Seizes 292 Rogue Websites; NABP Continues Efforts to Combat Counterfeit Medicines

Topics: Counterfeit drugs and Buying medicine online

An international coalition of law enforcement authorities recently shut down 292 websites selling counterfeit goods, including counterfeit prescription drugs.

Read More →

Abuse of Prescription Drugs by Indiana Teens Doubled in 2014, Indiana Youth Institute Reports

Topics: Prescription drug abuse

The number of teens who have abused prescription drugs in Indiana nearly doubled between 2003 and 2014, the most recent data from the Indiana Youth Institute indicates. 

Read More →

Governors of Two Northeastern States Announce Renewed Efforts to Combat Prescription Drug Abuse

Topics: Prescription drug abuse

New York Governor Andrew Cuomo and Massachusetts Governor Charlie Baker each revealed new steps being taken by the states in an effort to curb prescription drug abuse and the use of heroin.

Read More →

Partnership for Safe Medicines Releases Infographic to Help Users Identify Fake Online Pharmacies

Topics: Prescription drug abuse

With many illegal drug sellers operating websites that claim to be legitimate, the Partnership for Safe Medicines has released a new resource to help consumers identify the characteristics of a fake online pharmacy. 

Read More →

Legal Briefs: Peer Review

Topics: Pharmacists

A vast majority of administrative disciplinary matters are resolved short of a formal hearing through the entry of a settlement agreement, sometimes referred to as a consent order.

Read More →

FDA Releases Five Draft Documents Related to Compounding and Repackaging Requirements

Topics: Compounding and Fda

Food and Drug Administration (FDA) has issued five draft documents related to drug compounding and repackaging requirements under the Drug Quality and Security Act (DQSA). 

Read More →

Registration for Web Meeting on USP General Chapter <800> Closes Tomorrow

Topics: Pharmacists

To answer stakeholder questions regarding the republished General Chapter <800> Hazardous Drugs – Handling in Healthcare Settings (PDF), United States Pharmacopeial (USP) Convention is hosting an open microphone web online meeting on February 20, 2015, from 2 PM-4 PM EST.

Read More →

New FDA Drug Info Rounds Training Video Available

Topics: Pharmacists

In the latest Drug Info Rounds video, pharmacists discuss the many components of Risk Evaluation and Mitigation Strategies.

Read More →

Hospira Issues Recall for Multiple Lots of Ketorolac Tromethamine Injection Due to Potential Contamination

Topics: Compounding

Hospira, Inc, of Lake Forest, IL, has issued a voluntary recall of ketorolac tromethamine injection, USP in the US and Singapore due to potential particulate matter. 

Read More →

PTCB Celebrates Twenty Years of Technician Certification and Education

Topics: Pharmacy technicians

The Pharmacy Technician Certification Board (PTCB) is celebrating its twentieth anniversary.

Read More →

ACPE Releases Updated Definition of CPE and Guidance on CPD

Topics: Continuing education

The Accreditation Council for Pharmacy Education (ACPE) has released two documents that provide guidance and support for continuing pharmacy education (CPE) and continuing professional development (CPD).

Read More →

FDA Approves Zohydro ER with Abuse-Deterrent Properties

Topics: Prescription drug abuse and Fda

Food and Drug Administration (FDA) has approved a new formulation of Zohydro® ER with abuse-deterrent properties.

Read More →

Medical Marijuana May Have Therapeutic Benefits for Some Conditions, Surgeon General Says

Topics: Medical marijuana

Medical marijuana may help some patients, but the benefits must be shown scientifically, Surgeon General Vivek Murthy said.

Read More →

Rogue Internet Drug Seller Activity Highlights Need for .Pharmacy Domain Public Health Initiative

Topics: Counterfeit drugs and Buying medicine online

NABP has issued a report underscoring the need for the .Pharmacy Top-Level Domain (TLD) Program as a public health initiative to help consumers distinguish legitimate online pharmacies from rogue online drug sellers. 

Read More →

Presidential Budget Proposal Includes Investment to Curb Antibiotic-Resistant Bacteria

Topics: Federal regulations

President Obama’s 2016 budget includes nearly doubling the amount of federal funding for efforts aimed at combating and preventing antibiotic resistance. 

Read More →

Bill to Allow Imports of Canadian Drugs Reintroduced in Senate

Topics: Buying medicine online and Fda

Senators John McCain (R-AZ) and Amy Klobuchar (D-MN) have reintroduced the Safe and Affordable Drugs from Canada Act, which would allow individuals to import prescription drugs from Canada.

Read More →

Hospira Recalls One Lot of Sodium Chloride Injection Due to Particulate Matter

Topics: Compounding and Fda

Hospira, Inc, of Lake Forest, IL, has announced a voluntary nationwide recall of one lot of 0.9% Sodium Chloride Injection, USP, 250 mL (NDC 0409-7983-02,  expiration August 1) due to the presence of particulate matter. 

Read More →

FDA Warns of Counterfeit Cialis Tablets Entering the United States

Topics: Counterfeit drugs and Fda

Potentially dangerous, counterfeit versions of Cialis® 20 mg tablets were intercepted in the mail before reaching a US consumer, warns FDA.

Read More →

FDA Approves Non-Opioid Injectable Painkiller

Topics: Pain management and Fda

Food and Drug Administration recently approved DylojectTM Injection, a proprietary nonsteroidal anti-inflammatory drug.

Read More →

New Massachusetts Attorney General Wants to Strengthen the State’s PMP

Topics: Prescription monitoring program

Maura Healey, Massachusetts’ new attorney general, plans to strengthen the state’s prescription monitoring program as part of her larger goal of combating heroin use and prescription drug abuse

Read More →

New Mexico Senator to Sponsor Bill Requiring Retail Pharmacies to Start Medication Disposal Programs

Topics: Medication collection program disposal and Dea

New Mexico State Senator Michael Padilla plans to sponsor legislation that would require retail pharmacies to start collection programs for unused medications.

Read More →

FDA’s New Database Simplifies Searching for Guidance Documents

Topics: Federal regulations and Fda

FDA has unveiled a new database that houses most FDA guidance documents for regulatory professionals. 

Read More →

California Workgroup Shares New Prescribing Guidelines In Order to Help Reduce Prescription Drug Misuse

Topics: Controlled substances and Pain management

The California Prescription Opioid Misuse and Overdose Prevention Workgroup is providing information to health care providers on new prescribing guidelines for controlled substances for treating pain.

Read More →

Illinois Expands Medical Marijuana Program to Include Minors

Topics: Medical marijuana

The Illinois Department of Health has posted emergency rules regulating pediatric use of medical cannabis as part of the state’s new medical marijuana program.

Read More →

Most Drugs Sold by Rogue Online Drug Sellers Pose Serious Risks to Anyone Who Takes Them, Politico Reports

Topics: Counterfeit drugs and Internet pharmacy

Consumers who buy prescription drugs from illegal online drug sellers that advertise via spam or other disreputable methods are gambling with their lives.

Read More →

February DEA Conference on Preventing Drug Diversion Open to Pharmacy Personnel in Nevada

Topics: Diversion and Dea

Drug Enforcement Administration (DEA) is offering two regional one-day Pharmacy Diversion Awareness Conferences (PDACs) in Las Vegas, NV.

Read More →

Prescription Drug Abuse Among Teens Declined in 2014, Monitoring the Future Survey Finds

Topics: Prescription drug abuse

Abuse of most types of prescription drugs among teens declined in 2014, according to the 2014 Monitoring the Future Survey.

Read More →

Valeant Pharmaceuticals Issues Recall of Virazole Due to Microbial Contamination

Topics: Compounding and Fda

Valeant Pharmaceuticals of Bridgewater, NJ, has issued a voluntary recall of one lot of Virazole® (ribavirin powder for solution), 100 mL, 6g vial, 4-pack to the user level.

Read More →

Illegal Online Sales of Prescription Drugs Pose Challenge in the United Kingdom, The Guardian Reports

Topics: Counterfeit drugs and Buying medicine online

In 2014, the Medicines and Healthcare Products Regulatory Agency in the United Kingdom seized at least 1.2 million doses of illegally supplied erectile dysfunction drugs, 383,000 slimming products, and 331,000 doses of sleeping pills, tranquilizers, and antidepressants – mostly originating from China and India.

Read More →

Federal Ban on Medical Marijuana Ended by Congressional Spending Bill, LA Times Reports

Topics: Medical marijuana

A measure in the Congressional spending bill passed on December 13, 2014, has effectively ended the federal government’s ban on medical marijuana

Read More →

Pharmacy Compounding Advisory Committee Members Announced by FDA

Topics: Compounding and Fda

Food and Drug Administration has announced the names of the fourteen members of the Pharmacy Compounding Advisory Committee.

Read More →

Former NECC Employees Arrested, Face Charges Related to Fungal Meningitis Outbreak

Topics: Compounding

Fourteen people who worked for the New England Compounding Center (NECC), the facility linked to the fall 2012 fungal meningitis outbreak that resulted in the deaths of 64 people, have been arrested on charges related to the outbreak.

Read More →

Most Long-Term Opioid Users Take Dangerous Drug Combinations, Report Indicates

Topics: Pain management

Nearly 60% of patients using opioids on a long-term basis are taking a combination of drugs that can be dangerous and potentially life-threatening.

Read More →

Prescriptions for Anxiety, Sleep Medications Expose Teens to Abuse Risk

Topics: Prescription drug abuse

Teenagers prescribed sleep or anxiety medications such as Lunesta® or Xanax® are at greater risk of abusing those drugs than adolescents who have never been prescribed such medications, reports new research.

Read More →

FDA Issues New Labeling Rules for Drug Information to Benefit Pregnant, Breastfeeding Women

Topics: Prescription label and Fda

Food and Drug Administration (FDA) announced new prescription drug labeling requirements that will clarify how medications might affect women who are pregnant or breastfeeding and men and women of reproductive potential. 

Read More →

Aurobindo Pharma USA Recalls Northstar Label Gabapentin Capsules Due to Empty Capsule Reports

Topics: Fda

Aurobindo Pharma USA, Inc, of Dayton, NJ, has issued a voluntary recall of one lot (Lot Number GESB14011-A) of gabapentin capsules, USP 300 mg, 100-count bottles to the consumer level after finding that some capsules were empty.

Read More →

FDA Warns of More ‘Supplements’ Containing Hidden Drug Ingredients

Topics: Over the counter and Fda

Due to the presence of undeclared drug ingredients, FDA is warning consumers not to purchase or use certain products marketed as dietary supplements, including Slim Vie, Super Extreme Accelerator, and Black Storm.

Read More →

Milwaukee-Area Pharmacies Improve Adherence through Medication Synchronization Programs, BizTimes Reports

Topics: Patient counseling

Medication synchronization programs, which allow pharmacists to coordinate a patient’s medications to be refilled at the same time each month, are improving adherence rates and helping pharmacies in the Milwaukee area to improve workflow.

Read More →

Massachusetts County Kicks Off Public Safety Initiative to Reduce Prescription Drug Abuse

Topics: Prescription drug abuse

Law enforcement and emergency response officials in Norfolk County, MA, have kicked off a Prescription Drug Safety Initiative to help pharmacies identify possible signs of fraud or abuse.

Read More →

FDA Issues Final and Revised Draft Documents for Compounding Facilities Under DQSA

Topics: Compounding and Fda

Food and Drug Administration (FDA) has issued three additional guidance documents to help compounding entities register as outsourcing facilities. 

Read More →

FDA Approves New Abuse-Deterrent Single-Entity Hydrocodone Product

Topics: Prescription drug abuse and Fda

FDA has approved a new opioid analgesic medication with abuse-deterrent properties that make the drug difficult to crush, break, or dissolve. 

Read More →

College Student Abuse of Prescription Stimulants is Becoming ‘Normal,’ Survey Finds

Topics: Controlled substances and Prescription drug abuse

Approximately one in five college students abuse or misuse prescription stimulants such as Adderall® and Ritalin®.

Read More →

Pennsylvania Naloxone Law Goes into Effect This Week

Topics: Controlled substances and Prescription drug abuse

Beginning November 29, 2014, pharmacies in Pennsylvania may be requested to fill standing orders or prescriptions for the opioid reversal drug naloxone to first responders and friends and family of those at risk.

Read More →

North Dakota Voters Reject Pharmacy Ownership Ballot Measure

Topics: Pharmacies and Pharmacists

In North Dakota, residents rejected an Election Day ballot measure that would have removed a state requirement that pharmacies must be majority-owned by a licensed pharmacist.

Read More →

Dietary Supplements Mayhem and V26 Slimming Coffee Contain Hidden Drug Ingredients

Topics: Over the counter and Fda

Due to the confirmed presence of undeclared drug ingredients, Food and Drug Administration (FDA) is warning consumers not to purchase or use two products marketed as dietary supplements, Mayhem and V26 Slimming Coffee.

Read More →

Liver Injuries Caused by Dietary Supplements Are Rapidly Becoming More Common

Topics: Over the counter

Herbal and dietary supplements have contributed to liver abnormalities at substantially faster rate than those caused by medications over the last ten years, a study has found. 

Read More →

NABP to Begin Sunrise Trademark Registration Period for .Pharmacy Websites

Topics: Buying medicine online and Internet pharmacy

The National Association of Boards of Pharmacy® (NABP®) will soon be accepting applications for .pharmacy domain names from trademark holders who are registered in the Internet Corporation for Assigned Names and Numbers (ICANN) Trademark Clearinghouse (TMCH).

Read More →

Rhode Island Deploys NABP PMP InterConnect; 27 States Now Sharing PMP Data

Topics: Prescription monitoring program

The Rhode Island Prescription Monitoring Program (PMP) has deployed the NABP PMP InterConnect®, bringing the total number of live participating state PMPs to 27.

Read More →

Final Prescription Drug Take-Back Day Collects 617,150 Pounds of Unwanted Medications

Topics: Medication collection program disposal and Dea

Over 600,000 pounds of unneeded, unwanted, or expired prescription medications were properly disposed of during the final Drug Enforcement Administration (DEA) National Prescription Drug Take-Back Day, held September 27, 2014.

Read More →

WHO Recommends Increased Naloxone Access Worldwide

Topics: Prescription drug abuse

The World Health Organization (WHO) has released new guidelines aimed at reducing the number of opioid-related deaths globally.

Read More →

Colorado Issues 600 Notices to Medical Facilities Warning of Potential Doctor Shoppers

Topics: Diversion

Following legislation signed by Governor John Hickenlooper earlier this year, Colorado has issued 600 unsolicited report notices to medical facilities where some patients are suspected of doctor shopping. 

Read More →

San Francisco Considers Ordinance to Require Drug Manufacturers to Pay for Disposal

Topics: Medication collection program disposal

Supervisors in San Francisco are considering a city ordinance that would require drug manufacturers to fund disposal programs for unwanted prescription drugs. 

Read More →

Proliferation of Rogue Online Drug Sellers Feeds Prescription Drug Abuse Epidemic, NABP Reports

Topics: Counterfeit drugs and Buying medicine online

The National Association of Boards of Pharmacy® (NABP®) issued a new report highlighting a connection between the proliferation of rogue online drug sellers and the prescription drug abuse epidemic.

Read More →

Florida Voters Reject New Medical Marijuana Law

Topics: Medical marijuana

A proposed amendment to Florida's state constitution that would have legalized medical marijuana failed to reach the 60% margin required to be enacted.

Read More →

Prescription Opioids Involved in Most ED Overdoses, Study Finds

Topics: Prescription drug abuse

Prescription opioid medications are involved in over 67% of overdose cases in emergency departments, according to a national study published in JAMA Internal Medicine.

Read More →

Proliferation of Rogue Online Drug Sellers Feeds Prescription Drug Abuse Epidemic, NABP Reports

Topics: Counterfeit drugs and Buying medicine online

The National Association of Boards of Pharmacy® (NABP®) today issued a report highlighting a connection between the proliferation of rogue online drug sellers and the prescription drug abuse epidemic.

Read More →

Assured Brand Naproxen tablets Recalled Due to Packaging Error

Topics: Over the counter, Patient safety, and Fda

Contract Packaging Resources of Greensboro, NC, a drug repackaging company, is voluntarily recalling nearly 12,000 boxes of Assured brand naproxen sodium tablets because some cartons contain bottles of 200 mg ibuprofen softgels instead, a press release posted to the Food and Drug Administration (FDA) website indicates. 

Read More →

Hospira Recalls One Lot of Lidocaine HCl for Injection Due to Particulate Matter

Topics: Compounding and Fda

Hospira, Inc, of Lake Forest, IL, has announced a voluntary nationwide recall of one lot of 1% Lidocaine HCl for Injection, USP, 10 mg per mL, 30 mL single-dose, preservative-free due to the presence of particulate matter. 

Read More →

California Requires Outsourcing Facilities to Be Registered as Pharmacies if Compounding or Dispensing Drug Within or Into the State

Topics: Compounding

The California Board of Pharmacy is requiring outsourcing facilities to be registered as pharmacies if compounding or dispensing drugs within or into the state.

Read More →

FDA Plans to Study Effect of Color, Shape, and Size of Generic Drugs on Patient Adherence

Topics: Medication therapy management and Fda

FDA has proposed a survey of patients and pharmacists to determine how the color, shape, and size of a drug product affect patient adherence rates, particularly for generic drugs. 

Read More →

Pharmacy Robberies Plague Arizona, Other States, Says DEA

Topics: Diversion, Pharmacies, and Dea

Fueled by the prescription drug abuse epidemic, Arizona experienced the most pharmacy robberies in 2013 with 77 incidents, according to a report compiled by Drug Topics using Drug Enforcement Administration statistics. 

Read More →

FDA Orders New Jersey Company to Destroy Unapproved Drug Products

Topics: Fda

Federal authorities have ordered a New Jersey company to destroy its unapproved products and stop further manufacturing and distributing them until the drugs receive Food and Drug Administration (FDA) approval.

Read More →

FDA Announces Availability of Draft Guidance Regarding Licensure Standards Under Title II of the DQSA

Topics: Compounding and Fda

Food and Drug Administration (FDA) has issued a question-and-answer draft guidance document to assist industry and state governments in understanding the effects of section 585 (Uniform National Policy) of the Federal Food, Drug and Cosmetic Act added by Title II of the Drug Quality and Security Act (DQSA). 

Read More →

FDA Issues Draft Guidance on Pediatric Acetaminophen Products

Topics: Over the counter, Patient safety, and Fda

FDA has issued draft guidance with new recommendations for manufacturers of acetaminophen products.

Read More →

PTCB to Implement Changes in Continuing Education Requirements in 2015

Topics: Pharmacy technicians

The Pharmacy Technician Certification Board (PTCB) will implement two changes in recertification requirements for Certified Pharmacy Technicians (CPhTs) in accordance with its Certification Program changes announced in 2013. 

Read More →

FDA Provides Consumer Information on the Effect of OTC Medications on Driving

Topics: Patient safety and Fda

DA is reminding consumers that some over-the-counter (OTC) medications can affect the ability to drive and operate machinery safely in a new Consumer Update.

Read More →

Updated NABP Model Act Now Available to Assist Boards of Pharmacy in Developing Laws and Rules to Protect the Public Health

Topics: Pharmacies and Pharmacists

The recently amended NABP Model State Pharmacy Act and Model Rules of the National Association of Boards of Pharmacy (Model Act) is now available to assist the state boards of pharmacy in developing state laws or board rules in their efforts to protect the public health. 

Read More →

Rates of Prescription Opioid and Heroin Overdose Deaths Remain High in Many States, CDC Indicates

Topics: Prescription drug abuse

Heroin deaths increased sharply in at least 28 states from 2010 to 2012, and at least twice as many people died from prescription opioid overdoses, new information released by the Centers for Disease Control and Prevention (CDC) indicates.

Read More →

Prescription Painkiller Abusers are Rarely Prepared to Respond to Overdoses, Study Finds

Topics: Prescription drug abuse

Most teens and young adults who abuse prescription painkillers are rarely informed about overdose awareness, avoidance, and response strategies, even those with significant overdose experiences.

Read More →

New FDA Resource Provides Inspection, Compliance, and Recall Data

Topics: Fda

Food and Drug Administration (FDA) has released a new resource that provides access to comprehensive data on FDA inspections, warning letters, seizures and injunctions, and recall-related statistics.

Read More →

Patient Satisfaction Higher With Patient-Pharmacist Communication

Topics: Patient safety and Pharmacists

Patient satisfaction is higher when a pharmacist works with a patient to increase adherence and to thoroughly explain the risks and side effects of medications using multiple communication channels.

Read More →

White House Releases National Strategy for Combating Antibiotic-Resistant Bacteria

Topics: Cdc

The White House has released a document detailing a national strategy to curb antibiotic-resistant bacteria. 

Read More →

FDA Warns of Growing Network of Rogue Wholesale Drug Distributors

Topics: Counterfeit drugs and Fda

Food and Drug Administration (FDA) is warning pharmacists and other health care providers to watch for counterfeit and unapproved drugs through a new educational program known as Know Your Source.

Read More →

CDC Urges Flu Vaccinations for All Americans Over the Age of Six Months

Topics: Vaccinations and Cdc

Because less than half of Americans received flu vaccinations last year, according to a new CDC report, the agency is once again reminding the public that patients and caregivers of patients six months and older should be vaccinated. 

Read More →

Reminder: Final DEA Take-Back Day is Saturday, September 27

Topics: Medication collection program disposal and Dea

Consumers will have the opportunity to dispose of unneeded or unwanted medications at the last Drug Enforcement Administration (DEA) National Prescription Drug Take-Back Day on Saturday, September 27, 2014.

Read More →

Massachusetts Pharmacist Tied to 2012 Fungal Meningitis Outbreak Indicted

Topics: Compounding

A supervising pharmacist who worked for the New England Compounding Center (NECC), the facility linked to the fall 2012 fungal meningitis outbreak that resulted in the deaths of 64 people, has been indicted in US District Court on mail fraud charges related to the outbreak.

Read More →

Hospira Recalls One Lot of Heparin Sodium Due to Particulate Matter

Topics: Compounding and Fda

Hospira, Inc, of Lake Forest, IL, has announced a voluntary nationwide recall of one lot of Heparin Sodium, 1,000 USP Heparin Units/500 mL (2 USP Heparin Units/mL), in 0.9% sodium chloride injection 500 mL, due to the presence of particulate matter.

Read More →

California Passes Bill to Increase Role of Pharmacy Technicians

Topics: Pharmacy technicians

A California bill expanding the role of pharmacy technicians and interns was signed into law by Governor Jerry Brown on September 15, 2014. 

Read More →

FDA Issues New Warning Against Using NuVision Pharmacy Products

Topics: Compounding and Fda

Sterile-use drug products produced and distributed by Downing Labs, LLC, of Dallas, TX, doing business as NuVision Pharmacy, may not be safe, and should not be used.

Read More →

Pharmacy Creations Recalls Four Lots of Products Due to Sterility Concerns

Topics: Compounding and Fda

Pharmacy Creations of Randolph, NJ, has issued a voluntary recall of four lots of products after testing results found potential for lack of sterility.

Read More →

FDA to Host Public Meeting on Development and Regulation of Abuse-Deterrent Opioid Medications

Topics: Controlled substances, Prescription drug abuse, and Fda

FDA will host a public meeting to discuss the development, assessment, and regulation of abuse-deterrent formulations of opioid medications.

Read More →

Massive Opioid Diversion Case in New York Hospital Raises Concerns, Report Indicates

Topics: Controlled substances and Diversion

The arrest of the former director of pharmacy services for a large New York City hospital raises the question of how such facilities can ensure they are adequately protecting their controlled substance inventories from diversion.

Read More →

NABP Launches .Pharmacy Generic Top-Level Domain to Help Consumers Find Safe Pharmacies Online

Topics: Counterfeit drugs and Buying medicine online

NABP has launched the .pharmacy generic Top-Level Domain (gTLD) to provide consumers around the world a means for identifying safe, legal, and ethical online pharmacies and related resources.

Read More →

DEA Finalizes Rule on Controlled Substance Prescription Drug Disposal

Topics: Medication collection program disposal

Drug Enforcement Administration (DEA) has published its Final Rule on Disposal of Controlled Substances, allowing some DEA registrants to modify their registration to become authorized collectors. 

Read More →

National Decline in Rates of Prescription Drug Abuse in 2013, SAMHSA Reports

Topics: Prescription drug abuse

The number of people abusing prescription medications decreased from 6.8 million users in 2012, to 6.5 million users in 2013, according to the latest National Survey on Drug Use and Health.

Read More →

Martin Avenue Pharmacy Issues Voluntary Recall for All Sterile Compounded Preparations

Topics: Compounding

Martin Avenue Pharmacy, Inc, of Naperville, IL, has issued a voluntary recall for all in-date compounded sterile preparations due to a lack of sterility assurance. 

Read More →

Opioid-Related Overdose Deaths Increased from 2010 to 2013 in New York City, Report Indicates

Topics: Controlled substances and Prescription drug abuse

From 2010 to 2013, the rate of unintentional drug overdose deaths increased by 41% in New York City, and in 2013 77% of overdose deaths involved an opioid.

Read More →

States with Medical Marijuana Have Fewer Prescription Opioid Overdose Deaths, Study Claims

Topics: Controlled substances and Prescription drug abuse

Annual rates of overdose deaths related to prescription painkillers are an average of 24.8% lower in states with medical marijuana programs.

Read More →

DEA Reschedules Hydrocodone Combination Products as Schedule II

Topics: Controlled substances and Dea

Drug Enforcement Administration (DEA) has published its final rule rescheduling hydrocodone combination products from Schedule III to Schedule II in the Federal Register.

Read More →

FedEx Indicted on Additional Charges Related to Online Drug Sellers

Topics: Counterfeit drugs and Buying medicine online

FedEx is facing fresh allegations of conspiring to launder money related to the delivery of drugs sold by rogue online drug sellers.

Read More →

CDC Report Identifies Link Between Hospital Drug Diversion, Bacterial and Viral Infections

Topics: Patient safety

In 10 years, over 30,000 patients were exposed to pathogens through drugs diverted by infected medical professionals, a Centers for Disease Control and Prevention (CDC) report indicates. 

Read More →

Nearly Seventy US Ebola Scares Have Been Reported to CDC, ABC News Reports

Topics: Patient safety

In the United States, hospitals in 27 states have alerted CDC to possible Ebola cases out of an abundance of caution in the wake of the outbreak in western Africa.

Read More →

Google Agrees to Create $250 Million Program to Fight Rogue Online Drug Sellers

Topics: Counterfeit drugs, Buying medicine online, and Internet pharmacy

Google will create a $250 million internal program to “disrupt rogue online pharmacies,” as part of a deal to end shareholder litigation over its alleged placement of advertisements offering to sell prescription drugs from outside the United States, Reuters reports.

Read More →

Baxter Voluntarily Recalls Two Lots of Peritoneal Dialysis Solution Due to Particulate Matter

Topics: Compounding and Fda

Baxter International, Inc, of Deerfield, IL, has issued a voluntary recall of two lots of DIANEAL® Low Calcium (2.5mEq/L) Peritoneal Dialysis Solution with 2.5% Dextrose 5000mL (Ambu-Flex II) to the hospital/user level.

Read More →

FDA Warns of Additional ‘Supplements’ Containing Hidden Drug Ingredients

Topics: Over the counter

FDA is advising consumers not to purchase or use Herbal Vigor Quick Fix or Arize, two products marketed as dietary supplements for sexual enhancement, because they contain hidden drug ingredients.

Read More →

Prescription and OTC Painkillers Should be Used with Caution, Consumer Reports Advises

Topics: Over the counter and Prescriptions

Although medications such as OxyContin®, Percocet®, and Vicodin® can help patients manage pain from surgery, injury, or chronic illness, patients need to know the risks of both prescription and over-the-counter (OTC) medications.

Read More →

DEA to Hold Next Prescription Drug Take-Back Day on September 27, 2014

Topics: Medication collection program disposal and Dea

Drug Enforcement Administration (DEA) has announced another opportunity for consumers to dispose of unneeded and expired prescription drugs during the ninth DEA National Prescription Drug Take-Back Day.

Read More →

Seven Charged For Distributing Anabolic Steroids to High School and Professional Athletes

Topics: Dea

Law enforcement agents have arrested seven Florida residents on charges related to the distribution of anabolic steroids and other performance enhancing drugs from Florida-based Biogenesis of America.

Read More →

Hospira Recalls One Lot of 2% Lidocaine HCl Injection

Topics: Compounding and Fda

Hospira, Inc, of Lake Forest, IL, has initiated a voluntary recall of one lot of Lidocaine HCl Injection, USP, 2%, 20 mg per mL, 5mL Single-Dose Vial, due to the presence of visible particulate matter identified as iron oxide. 

Read More →

Mississippi Attorney General Targets Illicit Drug Advertisements on Google, Bloomberg Reports

Topics: Buying medicine online

Mississippi Attorney General Jim Hood plans to issue a civil investigative demand for more information from Google to determine whether the search company is profiting from illegal drug advertisements.

Read More →

Medication Synchronization Supported by Some Insurance Company Policies

Topics: Medication therapy management

Medication synchronization, programs that allow pharmacists to coordinate a patient’s medications to be refilled at the same time, may be accessible to more patients as insurers adopt policies to support the practice.

Read More →

Global Patient Safety Highlighted by NABP, Domestic and International Stakeholders at .Pharmacy Supporter Advisory Committee Meeting

Topics: Counterfeit drugs, Buying medicine online, and Patient safety

The National Association of Boards of Pharmacy® (NABP®) welcomed domestic and international stakeholders last week for a meeting of the .Pharmacy Supporter Advisory Committee.

Read More →

FDA Reiterates Warning Against Using NuVision Pharmacy Products

Topics: Compounding and Fda

Health care providers should not use or distribute compounded drugs marketed as sterile produced by Downing Labs, LLC, of Dallas, TX, also known as NuVision Pharmacy.

Read More →

Unique Pharmaceuticals Recalls All Sterile Compounded Preparations Due to Lack of Sterility Assurance

Topics: Compounding

Unique Pharmaceuticals, Ltd, of Temple, TX, has announced a voluntary recall of all sterile drug preparations compounded by the outsourcing facility.

Read More →

FDA Approves New Abuse-Deterrent Opioid Pain Medication

Topics: Controlled substances and Fda

FDA has approved Targiniq™ ER, an opioid pain reliever designed to be more resistant to abuse.

Read More →

NIDA Announces Development of New System to Monitor Drug Abuse Trends

Topics: Prescription drug abuse

Intended to identify information that will help health experts respond quickly to potential outbreaks of illicit drug use and abuse, a new National Drug Early Warning System is under development.

Read More →

FedEx Indicted Over Role in Delivering Misbranded Prescription Drugs Ordered from Illegal Online Drug Sellers

FedEx Corporation has been indicted by a federal grand jury in San Francisco, CA,  in connection with its alleged role in trafficking controlled substances (CS) and misbranded prescription drugs for rogue online drug sellers.

Read More →

Baxter Recalls Four Lots of IV Solution Due to Particulate Matter

Baxter International Inc, of Deerfield, IL, has recalled four lots of intravenous (IV) solutions due to the presence of particulate matter. 

Read More →

Pennsylvania Task Force Releases Voluntary Opioid Prescription Guidelines

Topics: Prescription drug abuse

The Safe and Effective Prescribing Practices and Pain Management task force has created voluntary prescribing guidelines for the treatment of chronic non-cancer pain, under the direction of Governor Tom Corbett. 

Read More →

JCPP Releases New Patient-Care Document to Promote Consistency

The Joint Commission of Pharmacy Practitioners (JCPP) has released a resource document aimed at promoting consistency in the pharmacists’ process of patient care service delivery.

Read More →

DEA Classifies Tramadol a Controlled Substance

Topics: Controlled substances and Fda

Under a final rule (PDF) published in the Federal Register, the pain reliever tramadol is now classified as a Schedule IV controlled substance (CS). 

Read More →

Massachusetts Bill Includes New Requirements for Compounders, Fines for Violations

Topics: Compounding

Aimed to ensure the safety of compounded medications, legislation in Massachusetts includes new inspection requirements and fines for violations, among other provisions. 

Read More →

DSCSA Draft Guidance Webinar Available to Assist Small Businesses

Topics: Compounding and Fda

Food and Drug Administration (FDA) Center for Drug Evaluation and Research Small Business and Industry Assistance (CDER SBIA) hosted a webinar.

Read More →

Florida Sees Dramatic Drop in Prescription Drug Overdose Deaths

Topics: Prescription drug abuse and Prescription monitoring program

A number of policy and law enforcement measures helped reduce Florida’s prescription drug overdose death rate by 23% from 2010 to 2012, reports Centers for Disease Control and Prevention (CDC).

Read More →

FDA Releases DQSA Compounding Rules and Guidance Documents

Topics: Compounding and Fda

Food and Drug Administration (FDA) has released several policy documents related to compounding as part of the agency’s implementation of the Drug Quality and Security Act (DQSA).

Read More →

Counterfeit Antibiotics Contributing to ‘Superbug’ Threat, Bloomberg Reports

Topics: Counterfeit drugs and Buying medicine online

Often distributed by rogue Internet drug outlets, counterfeit medications containing antibiotics are feeding a “global epidemic” of antibiotic-resistant infections.

Read More →

Lidocaine Should Not Be Used to Treat Teething Pain in Children, FDA Warns

Topics: Over the counter and Fda

FDA is recommending that prescription oral viscous lidocaine 2% solution should not be used to treat infants and children with teething pain.

Read More →

New York Governor Signs Laws Aimed at Combating Opioid Prescription Drug Abuse Epidemic

Topics: Prescription drug abuse

A legislative package of 11 bills targeting prescription drug and opioid abuse has been approved by New York Governor Andrew Cuomo. 

Read More →

Massachusetts Law Will Allow Substitutions of Interchangeable Biologic Medicines

Topics: Fda

Massachusetts Governor Deval Patrick has signed HB 3734 allowing for the substitution of interchangeable biosimilars. 

Read More →

NABP Executes Registry Agreement with ICANN for .Pharmacy Domain

Topics: Counterfeit drugs, Buying medicine online, and Patient safety

Consumers Worldwide Will Soon Have New Tool for Finding Safe Internet Pharmacies

Read More →

Buyers Should Be Wary of Sites Claiming to be Legitimate Internet Pharmacies from Other Countries, Consumer Reports Advises

Topics: Counterfeit drugs and Buying medicine online

Buying medications online from other countries is dangerous since many websites claiming to be an Internet pharmacy from a particular country are not located in that country and are in fact operating illegally, as reflected in an article from Consumer Reports

Read More →

FDA Consumer Update Warns of Hidden Drugs in Bee Pollen ‘Supplements’

Topics: Over the counter, Contamination, and Fda

Noting that more than 50 adverse event reports associated with the use of certain bee pollen products have been submitted to Food and Drug Administration, the Agency has released a Consumer Update warning that such products, marketed as dietary supplements, often contain hidden drug ingredients that can be harmful.

Read More →

Illinois PMP Implements New Long-Term Care Initiative

Topics: Prescription monitoring program

With growing concerns regarding substantial use of behavioral health medications among nursing home populations, the Illinois Department of Human Services and the Illinois Department of Public Health have announced the Prescription Monitoring Program Long Term Care initiative.

Read More →

NABP Executes Registry Agreement with ICANN for .Pharmacy Domain

Topics: Counterfeit drugs, Buying medicine online, and Patient safety

Consumers Worldwide Will Soon Have New Tool for Finding Safe Internet Pharmacies

Read More →

FDA Releases Draft Guidance on Identifying Suspect Drugs Under DSCSA

Topics: Compounding, Diversion, and Fda

Food and Drug Administration (FDA) has published a draft guidance document for prescription drug supply chain stakeholders as part of the agency’s implementation of the Drug Supply Chain Security Act (DSCSA).

Read More →

New England Governors Convene for Regional Summit Addressing Opioid Abuse

Topics: Diversion and Prescription drug abuse

Governors of five New England states convened for a regional opioid drug abuse summit on June 17, 2014.

Read More →

Michigan Legislature Passes Two Bills in Effort to Reduce Meth Production

Topics: Over the counter and Pseudoephedrine

In Michigan, state lawmakers have passed a package of bills aimed at reducing production of illegal methamphetamine by targeting “smurfs.”

Read More →

Cannabis-Based Medication Receives Fast Track Status, May Affect State Medical Marijuana Laws

Topics: Medical marijuana and Fda

Epidiolex®, an “investigational cannabidiol product” developed by GW Pharmaceuticals, has received Fast Track designation from FDA for the treatment of Dravet syndrome.

Read More →

Drug Supply Chain Security Act Public Workshop Summary Now Available

Topics: Compounding and Fda

Food and Drug Administration (FDA) held a public workshop on the development of initial standards for the interoperable exchange of transaction information, transaction history, and transaction statements, as required by the Drug Supply Chain Security Act.

Read More →

Amazon Accused of Enabling Prescription Drug Diversion

Topics: Counterfeit drugs and Buying medicine online

Amazon, the world’s largest online retailer, is enabling unlawful sales of steroids, muscle relaxants, prescription antibiotics, and other dangerous, often illicit substances, an investigative report from Slate alleges.

Read More →

ASHP and ACPE Announce New Commissioners for the Pharmacy Technician Accreditation Commission

Topics: Pharmacists

The American Society of Health-System Pharmacists (ASHP) and the Accreditation Council for Pharmacy Education (ACPE) have announced the first commissioners for the Pharmacy Technician Accreditation Commission (PTAC). 

Read More →

Alexion Pharmaceuticals Recalls Soliris Lots Due to Presence of Visible Particles

Topics: Compounding and Fda

Alexion Pharmaceuticals of Cheshire, CT, has initiated a voluntary recall for certain lots of Soliris® (eculizumab) 300 mg/30 mL concentrated solution for intravenous infusion due to the presence of visible proteinaceous particles detected in one lot during periodic testing. 

Read More →

FDA Proposes New Tobacco Rules Affecting Liquid Nicotine Products Used in E-Cigarettes

Topics: Patient safety and Fda

Food and Drug Administration (FDA) has released proposed rules that would place additional tobacco products, including liquid nicotine products and electronic cigarettes, under FDA authority. 

Read More →

FDA Lowers Recommended Starting Dose for Lunesta Due to Risk of Morning Impairment

Topics: Patient safety and Fda

FDA has lowered the recommended starting dose of the sleep drug Lunesta®

Read More →

New Study Highlights Key Quality Standards for Large-Scale Sterile Compounding

Topics: Compounding

A new study comparing safety measures used by pharmaceutical manufacturing facilities with those used by compounding facilities highlights the quality standards that are needed by all compounding facilities.

Read More →

FDA Detains Hundreds of Packages Containing Illegal Prescription Drugs Bound for US Consumers

Topics: Counterfeit drugs, Buying medicine online, and Fda

As part of the seventh annual International Internet Week of Action, FDA and Customs and Border Protection detained and seized 583 packages of illegal prescription drugs.

Read More →

Unapproved Drugs Seized by US Marshals at Request of FDA

Topics: Counterfeit drugs and Fda

At the request of FDA and the United States Attorney for the Southern District of Ohio, US Marshals have seized more than $11 million worth of unapproved drugs.

Read More →

Twenty-Five States’ Prescription Data Now Linked Through NABP PMP InterConnect

Topics: Counterfeit drugs, Diversion, and Prescription drug abuse

Supporting state efforts to fight prescription drug abuse, participation in the National Association of Boards of Pharmacy® (NABP®) PMP InterConnect® program continues to grow with 25 prescription monitoring programs now live.

Read More →

NABP 2014-2015 Executive Committee Inaugurated at 110th Annual Meeting in Phoenix, AZ

Delegates to the National Association of Boards of Pharmacy® (NABP®) 110th Annual Meeting, held May 17-20, 2014, in Phoenix, AZ, elected individuals to fill the president-elect, treasurer, and open member positions on the Association’s 2014-2015 Executive Committee.

Read More →

Karen M. Ryle, MS, RPh, Assumes Chair of NABP 2014-2015 Executive Committee, Receives President’s Award

Karen M. Ryle, MS, RPh, immediate past president of the National Association of Boards of Pharmacy® (NABP®), assumed the office of chairperson of the Association’s 2014-2015 Executive Committee during the Final Business Session of the NABP 110th Annual Meeting, held May 17-20, 2014, in Phoenix, AZ.

Read More →

Delegates Approve Eight Resolutions at the NABP 110th Annual Meeting

Delegates from the member boards of pharmacy adopted eight resolutions during the National Association of Boards of Pharmacy® (NABP®) 110th Annual Meeting, held May 17-20, 2014, in Phoenix, AZ.

Read More →

Joseph L. Adams, RPh, Begins Term as NABP President During the Association’s 110th Annual Meeting

Joseph L. Adams, RPh, began his term as president of the National Association of Boards of Pharmacy® (NABP®) during the Final Business Session of the Association’s 110th Annual Meeting, May 17-20, 2014, in Phoenix, AZ.

Read More →

Edward G. McGinley, MBA, RPh, Elected NABP President-elect at Association’s 110th Annual Meeting

Edward G. McGinley, MBA, RPh, was elected to serve as the 2014-2015 president-elect of the National Association of Boards of Pharmacy® (NABP®) during the Association’s 110th Annual Meeting, May 17-20, 2014, in Phoenix, AZ. 

Read More →

Hal Wand, MBA, RPh, Elected NABP Treasurer at Association’s 110th Annual Meeting

Hal Wand, MBA, RPh, was elected to serve as the 2014-2015 treasurer of the National Association of Boards of Pharmacy® (NABP®) during the Association’s 110th Annual Meeting, May 17-20, 2014, in Phoenix, AZ.

Read More →

Jack W. “Jay” Campbell IV, JD, RPh, Elected to Serve as Member of Executive Committee at NABP 110th Annual Meeting

Jack W. “Jay” Campbell IV, JD, RPh, was elected to serve a three-year member term, representing District 3, on the Executive Committee of the National Association of Boards of Pharmacy® (NABP®) during the Association’s 110th Annual Meeting, May 17-20, 2014, in Phoenix, AZ.

Read More →

Philip P. Burgess, MBA, DPh, RPh, Elected to Serve as Member of Executive Committee at NABP 110th Annual Meeting

Philip P. Burgess, MBA, DPh, RPh, was elected to serve a three-year member term, representing District 4, on the Executive Committee of the National Association of Boards of Pharmacy® (NABP®) during the Association’s 110th Annual Meeting, May 17-20, 2014, in Phoenix, AZ.

Read More →

Richard B. Mazzoni, RPh, Elected to Serve as Member of Executive Committee at NABP 110th Annual Meeting

Richard B. Mazzoni, RPh, was elected to serve a three-year member term, representing District 8, on the Executive Committee of the National Association of Boards of Pharmacy® (NABP®) during the Association’s 110th Annual Meeting, May 17-20, 2014, in Phoenix, AZ.

Read More →

New Educational Video for Pharmacists Addresses Prescription Drug Abuse

Topics: Diversion and Prescription drug abuse

The National Association of Boards of Pharmacy® (NABP®) and the Anti-Diversion Industry Working Group, a consortium of pharmaceutical manufacturers and distributors, has released an educational video for pharmacists to help them identify the warning signs of prescription drug abuse and diversion when dispensing controlled substance prescriptions.

Read More →

Record Amount of Unwanted Medications Collected During Eighth Prescription Drug Take-Back Day

Topics: Medication collection program disposal

Nearly 800,000 pounds of unneeded prescription medications were properly disposed of during the April 26, 2014, Drug Enforcement Administration National Prescription Drug Take-Back Day.

Read More →

Hidden Sibutramine Found in Two Products Marketed for Weight Loss, FDA Warns

Topics: Fda

Due to the presence of undeclared sibutramine, Food and Drug Administration (FDA) is advising consumers not to use Natural Body Solution or Slim Trim U products marketed for weight loss and sold in stores and on websites. 

Read More →

Pennsylvania Bill Would Expand the State’s PMP to Include All CS Prescriptions

Topics: Prescription monitoring program

Aimed to help fight prescription drug abuse, proposed legislation in Pennsylvania would establish a comprehensive prescription monitoring program.

Read More →

Canadian Drug Seller is Violating State Law, Rules Maine Board of Pharmacy

Topics: Buying medicine online

In a unanimous decision, the Maine Board of Pharmacy directed the state’s attorney general to issue a cease-and-desist letter to Canada Drug Center, a company that has been marketing prescription drugs in Maine.

Read More →

Compounding Facilities Invited to Participate in 2014 USP Chapter <797> Compliance Study

Topics: Compounding and Pharmacists

Sterile compounding practices are invited to participate in the 2014 United States Pharmacopeia (USP) <797> Compliance Study. 

Read More →

Florida House of Representatives Approves Bill to Increase the Number of Pharmacy Technicians a Pharmacist can Oversee

Topics: Pharmacists and Pharmacy technicians

A bill that would increase the number of pharmacy technicians a pharmacist may supervise has passed the Florida House of Representatives. 

Read More →

New Requirements for Some Painkiller Prescriptions Help to Lower Addiction Risk, Massachusetts Insurer Reports

Topics: Controlled substances

After implementing stricter requirements for certain painkiller prescriptions, Blue Cross and Blue Shield of Massachusetts, the state’s largest private health insurer, has released the results of an “18-month checkup.” 

Read More →

Super Arthgold ‘Supplement’ Recalled Due to Undeclared Drug Ingredients

Topics: Over the counter and Fda

Nano Well-being Health, Inc, of La Mirada, CA, has issued a voluntary recall of two lots of Super Arthgold, a product promoted and sold as a dietary supplement for joint, muscle, and arthritic pain.

Read More →

2014 National Prescription Drug Abuse Summit Presentations Now Available

Topics: Prescription drug abuse

Bringing together clinical experts and representatives from state and federal governments, the 2014 National Rx Drug Abuse Summit took place April 22-24, 2014, in Atlanta, GA.

Read More →

Reminder: DEA Take-Back Day Is Saturday, April 26

Topics: Medication collection program disposal and Dea

Consumers will have the opportunity to dispose of unneeded or unwanted medications at a Drug Enforcement Administration National Prescription Drug Take-Back Day collection site on Saturday, April 26, 2014.

Read More →

FDA Developing Track and Trace Standards as Part of DSCSA Implementation

Topics: Counterfeit drugs, Buying medicine online, and Fda

To protect consumers from drugs that may be counterfeit, stolen, or tainted, Food and Drug Administration is advancing efforts to implement an advanced track and trace program.

Read More →

Prescription Drug Abuse Workgroup Formed in Senate Health Committee

Topics: Federal regulations and Prescription drug abuse

The Senate Committee on Health Education Labor and Pensions is establishing a working group to address the national prescription drug abuse epidemic. 

Read More →

Massachusetts Cannot Ban Hydrocodone-Only Medications, Federal Judge Rules

Topics: Controlled substances and Fda

A US District Judge has ruled that Massachusetts may not ban the prescribing and dispensing of hydrocodone-only medication products that have been approved by FDA.

Read More →

Canadian Drug Seller Fills Maine Prescriptions in India, Alleges Maine Pharmacy Association President

Topics: Counterfeit drugs and Buying medicine online

A Canadian company is allegedly filling prescriptions in India and other countries for patients in Maine, according to a complaint filed by the president of the Maine Pharmacy Association.

Read More →

FDA Warns Consumers Not to Use Lite Fit USA and Infinity ‘Supplements’ Due to Hidden Drug Ingredients

Topics: Patient safety and Fda

Food and Drug Administration is advising consumers not to purchase or use Lite Fit USA and Infinity, two products marketed as dietary supplements for weight loss.

Read More →

New FDA Drug Info Rounds Training Video Available

Topics: Pharmacists and Fda

In the latest FDA Drug Info Rounds video, pharmacists discuss how to search the “Electronic Orange Book.”

Read More →

Legal Briefs: Court Documents License for Undocumented Licensee

Topics: Federal regulations

The interaction and potential conflict between federal and state law can present interesting issues for regulatory boards that, at times, may be difficult to reconcile.

Read More →

DEA Prescription Drug Take-Back Day Collection Site Locator Now Available

Topics: Prescription drug abuse

Now available online, the Drug Enforcement Administration (DEA) National Prescription Drug Take-Back Day collection site locator allows consumers to search for a nearby location to dispose of unneeded medications on Saturday, April 26, 2014. 

Read More →

NCPDP Recommends Standardized Metric Measurements on Oral Liquid Medication Labels

Topics: Prescription label

The National Council for Prescription Drug Programs (NCPDP) has issued new recommendations and guidance for standardizing the dosing designation used on prescription container labels of oral liquid medications dispensed by community pharmacies in order to reduce dosing errors. 

Read More →

Opioid Addiction Epidemic Declared Public Health Emergency in Massachusetts

Topics: Prescription drug abuse

In response to a growing number of opioid-related deaths, Massachusetts Governor Deval Patrick declared a public health emergency. 

Read More →

USP Proposes New General Chapter Addressing Compounding of Hazardous Drugs

Topics: Compounding

In an effort to protect health care providers and personnel who handle hazardous drugs, United States Pharmacopeial Convention (USP) has proposed new General Chapter <800> Hazardous Drugs – Handling in Healthcare Settings.

Read More →

Countryside Police Department to Implement Cook County’s First Overdose Prevention Program

Topics: Prescription drug abuse

The Countryside Police Department has received approval to implement a new Overdose Prevention Program in partnership with the Chicago Recovery Alliance. 

Read More →

Bill Requiring Coverage of Partial Refills to Support Medication Synchronization Efforts Introduced in Missouri

Topics: Medication therapy management

Aimed to promote patient care, a Missouri bill would require that health benefit plans reimburse when pharmacies dispense less than a 30-day supply for the purpose of synchronizing a patient’s chronic medications.

Read More →

Shire Recalls Three Lots of VPRIV Due to Particulate Matter

Topics: Patient safety and Fda

Shire Pharmaceuticals has initiated a voluntary recall of three lots of VPRIV® (velaglucerase alfa for infusion) due to the presence of particulate matter, identified as stainless steel and barium sulfate.

Read More →

Study Underscores Importance of Multifaceted Strategy to Reduce Opioid Overdoses

Topics: Prescription drug abuse

A group of investigators at Massachusetts General Hospital recently analyzed factors that increased the risk of recurrent opioid overdoses requiring emergency department visits.

Read More →

Legal Briefs: JK on the 120 Days

Topics: Pharmacists

To the consumer (and perhaps the legislature), the time it takes to process, investigate, formally charge, and adjudicate an administrative complaint (or negotiate a consent order) can appear to be lengthy.

Read More →

Legislation to Withdraw Approval of New Painkiller Introduced to Congress

Topics: Pain management and Fda

Senator Joe Manchin (D-WV) has introduced Senate Bill 2134 (PDF), which would withdraw Food and Drug Administration (FDA) approval of Zohydro™ ER (hydrocodone bitartrate).

Read More →

Internet Drug Outlet Fraudulently Claiming NABP Accreditation

Topics: Buying medicine online

Recently, NABP discovered that the Internet drug outlet, WellnessFitnessNutrition, LLP (WFN), was fraudulently claiming to hold certain NABP certifications. 

Read More →

Pain Free by Nature Recalls Reumofan Plus Tablets, Undeclared Drug Ingredients Discovered

Topics: Patient safety and Fda

Pain Free by Nature, LLC, of Woodland Park, CO, is recalling all “Reumofan Plus” tablets purchased through its website because they contain undeclared methocarbamol and diclofenac, making the product an unapproved drug. 

Read More →

US Attorney General Urges Increase in Accessibility of Naloxone

Topics: Prescription drug abuse

US Attorney General Eric Holder called the rise in overdose deaths from prescription painkillers and heroin an “urgent public health crisis.”

Read More →

Pfizer Pulls Three Lots of Anti-Depressant Medication Over Health, Safety Concerns

Topics: Patient safety

Pfizer, Inc, has voluntarily recalled three lots of its anti-depressant medication, Effexor XR®.

Read More →

Prescribers Can Play Important Role in Reducing Painkiller Overdose, CDC Reports

Topics: Controlled substances and Prescription drug abuse

People who frequently abuse opiate painkillers are often at the highest risk of overdosing, and are also likely to obtain the drugs through multiple prescriptions and multiple doctors, a practice known as “doctor shopping.”

Read More →

CDC Provides Recommendations for Antibiotic Prescribing Practices

Topics: Patient safety and Practitioner prescriber

CDC has issued new warnings about prescribing practices for antibiotics.

Read More →

DEA Announces Temporary Scheduling of 10 Synthetic Cathinones

Topics: Controlled substances and Dea

The administrator of Drug Enforcement Administration (DEA) has issued a final order to temporarily schedule 10 synthetic cathinones into Schedule I of the Controlled Substances Act effective as of March 7, 2014. 

Read More →

DEA Publishes Proposed Rulemaking to Reschedule Hydrocodone Products, Invites Public Comment

Topics: Controlled substances, Prescription drug abuse, and Dea

New rules for hydrocodone combination products that would move the controlled substance medications from Schedule III to Schedule II have been proposed by Drug Enforcement Administration.

Read More →

FDA Announces Public Hearing on OTC Drug Review Process

Topics: Over the counter and Fda

FDA has announced a public hearing to review the agency’s Over-the-Counter Drug Review process, including strengths and weaknesses of the current process and ideas about modifications or alternatives.

Read More →

FDA Develops Drug Supply Chain Security Act Implementation Plan

Topics: Counterfeit drugs, Diversion, and Fda

Food and Drug Administration has developed a 10-year plan for implementation of the Drug Supply Chain Security Act.

Read More →

FDA Initiates the Secure Supply Chain Pilot Program to Enhance Security of Imported Drugs

Topics: Counterfeit drugs, Diversion, and Fda

Established to enhance the security of imported drugs, FDA’s Secure Supply Chain Pilot Program will launch with the participation of 13 companies prequalified by the agency.

Read More →

GAO Study Finds FDA Actions Have Reduced New Drug Shortages, Recommends Additional Action

Topics: Fda

Steps taken by FDA have successfully reduced the number of new drug shortages, and a new study from the Government Accountability Office urges the agency to take additional steps to reduce the number of overall drug shortages. 

Read More →

NABP Moves .Pharmacy Program Closer to Launch, Enters Contracting Phase With ICANN

Topics: Counterfeit drugs, Buying medicine online, and Prescription drug abuse

Moving one step closer to providing consumers worldwide with an easy way to identify safe online pharmacies and resources, the National Association of Boards of Pharmacy® (NABP®) has been deemed eligible to enter contract negotiations with the Internet Corporation for Assigned Names and Numbers (ICANN) to own and operate the .pharmacy domain suffix.

Read More →

ACPE Releases Draft Standards for Pharmacy Professional Programs for Public Comment

Topics: Pharmacists and Pharmacy technicians

The Accreditation Council for Pharmacy Education has released the Draft Revised Standards for the Professional Program Leading to the Doctor of Pharmacy Degree and the Guidance Document to Standards 2016 for public review and comment.

Read More →

Missouri Legislature Considers Bill to Establish a PMP

Topics: Prescription monitoring program

The Missouri House of Representatives has approved a bill that would establish a prescription monitoring program.

Read More →

West Virginia Considering Legislation to Make PSE Prescription-Only

Topics: Over the counter

Aimed to reduce the illegal manufacture and abuse of methamphetamine, a bill that would make pseudoephedrine medications available by prescription only has passed the West Virginia Senate.

Read More →

Arth-Q Supplement Should Not Be Used Due to Hidden Ibuprofen, FDA Warns

Topics: Patient safety and Fda

Consumers should not purchase or use Arth-Q, a product promoted and sold as a dietary supplement for joint, muscle, and arthritic pain, Food and Drug Administration warns.

Read More →

CVS Caremark Plans to Stop Selling Tobacco Products

Topics: Patient safety

CVS Caremark has announced its plan to stop selling tobacco products in all of its stores by October 1, 2014, in support of patient and customer health. 

Read More →

Bill to Restrict DXM Sales to Adults Introduced to House

Topics: Over the counter and Prescription drug abuse

Aimed to reduce the abuse of cough medications, the Preventing Abuse of Cough Treatments of 2014 Act (PACT Act), has been introduced to the United States House of Representatives.

Read More →

New York’s Strengthened PMP Helped Cut “Doctor Shopping” by 75%

Topics: Controlled substances and Prescription drug abuse

Since the implementation of New York state’s Internet System for Tracking Over-Prescribing Act (I-STOP) in August 2013, “doctor shopping” – when patients visit multiple doctors to obtain controlled substance medications – has been reduced by 75%.

Read More →

Medical Clinic Owner, 23 Others Charged in Alleged Pill Mill Scheme

Topics: Counterfeit drugs and Diversion

Kevin Lowe, former owner and operator of a Bronx, NY medical clinic and 23 others have been arrested on charges related to a massive “pill mill” operation that involved approximately 31,500 medically unnecessary prescriptions for oxycodone with an estimated street value of up to $550 million.

Read More →

California Bill Would Allow Pharmacists to Dispense Naloxone Under Approved Protocol

Topics: Pharmacists

In response to the growing rate of opiate overdose fatalities in California, a bill aimed at expanding access to naloxone hydrochloride has been introduced to the state assembly.

Read More →

Former Denver Pharmacist Sentenced to 15 Years for Involvement in Oxycodone Trafficking

Topics: Diversion

A former pharmacist, Jeffrey Clawson, has been sentenced to a 15-year term in Adams County Community Corrections for his role in an oxycodone trafficking scheme.

Read More →

FDA Prohibits Facility from Producing and Distributing Drug Ingredients for US Market

Topics: Compounding and Fda

A Food and Drug Administration decree has prohibited Ranbaxy Laboratories, Ltd, from manufacturing and distributing active pharmaceutical ingredients from the company’s facility in Toansa, India, for use in FDA-regulated drug products. 

Read More →

High Rates of Drug Overdoses in Pennsylvania Prompt Legislative Action

Topics: Prescription drug abuse

In 2011, Pennsylvania had the 14th highest rate of drug overdose deaths in the country, with counties in the southwestern portion of the state experiencing even higher rates of overdose deaths.

Read More →

Pharmacist Pleads Guilty to Illegally Dispensing Prescription Painkillers

Topics: Diversion

Leonard “Lenny” Stefanelli, the former pharmacist-in-charge of West Orange Pharmacy, West Orange, NJ, admitted to illegally dispensing hundreds of tablets of OxyContin® and for submitting fraudulent bills to health care benefit providers over the course of two decades.

Read More →

ACPE Elects Executive Committee and Board Liaisons for 2014-2015

Topics: Continuing education and Pharmacists

The Accreditation Council for Pharmacy Education has announced the members of the 2014-2015 ACPE Executive Committee.

Read More →

USP Posts FAQs to Address Common Questions About USP-NF Chapters <795> and <797>

Topics: Federal regulations

In response to questions concerning United States Pharmacopeia-National Formulary General Chapters <795> and <797>, USP has created a new frequently asked questions page on its website.

Read More →

Mentholatum Company Recalls Some Rohto Eye Drops Products Manufactured in Vietnam

Topics: Patient safety and Fda

he Mentholatum Company of Orchard Park, NY, has issued a voluntary recall of some Rohto eye drop products due to a manufacturing review at the production facility in Vietnam involving sterility controls.

Read More →

DEA to Hold Next Prescription Drug Take-Back Day on April 26, 2014

Topics: Diversion and Dea

Drug Enforcement Administration has announced another opportunity for consumers to dispose of unneeded and expired prescription drugs.

Read More →

FDA Requests that Health Care Providers and Regulators Encourage Outsourcing Facility Registration

Topics: Compounding and Fda

Food and Drug Administration (FDA) Commissioner Margaret Hamburg has encouraged entities that purchase compounded sterile drugs to meet the medical needs of patients that cannot be met by FDA-approved products to consider requiring their providers to register as outsourcing facilities with FDA. 

Read More →

Compounding Entities Begin to Register With FDA as Outsourcing Facilities

Topics: Compounding and Fda

Fourteen facilities are the first to be registered as Human Drug Compounding Outsourcing Facilities with Food and Drug Administration (FDA) under the DQSA. 

Read More →

Acetaminophen Prescription Combination Drug Products With More Than 325 mg: FDA Statement – Recommendation to Discontinue Prescribing and Dispensing

Topics: Prescriptions and Fda

In light of all the recent news alerts and warnings about the use of acetaminophen and acetaminophen containing products, the FDA issued a recommendation of importance to pharmacists, prescribers, and patients.

Read More →

New York State to Permit Limited Medical Marijuana Prescribing

Topics: Medical marijuana

New York Governor Andrew Cuomo plans to announce an executive action that would permit limited prescribing of medical marijuana in up to 20 hospitals within the state. 

Read More →

Baxter International Recalls Select Lots of CLINIMIX and CLINIMIX E Due to Complaints of Particulates

Topics: Compounding and Fda

Baxter International Inc, has issued a voluntary recall of two lots of CLINIMIX and one lot of CLINIMIX E Injection parenternal nutrition products to the user level following complaints of particulate matter found in the products. 

Read More →

FDA Warns Consumers Not to Use Mass Destruction, a Dietary Supplement Sold Online and in Retail Stores

Topics: Buying medicine online and Fda

Mass Destruction, a product marketed online and in retail stores as a dietary supplement for muscle growth, has been associated with at least one reported serious illness, reports FDA.

Read More →

Court Grants Temporary Injunction Against OK Compounding

Topics: Compounding

On August 29, 2013, the District Court of Tulsa County in the state of Oklahoma granted a temporary injunction to enjoin the defendants, including Christopher Parks and OK Compounding, LLC (collectively, OK Compounding), from engaging in certain conduct in connection with plaintiff Rush University Medical Center (Rush). 

Read More →

Abrams Royal Compounding Pharmacy Recalls All Lots of Unexpired Sterile Products Due to Lack of Sterility Assurance

Topics: Compounding and Fda

Abrams Royal Compounding Pharmacy of Dallas, TX, and Food and Drug Administration (FDA) have announced a voluntary recall of all unexpired lots of sterile products after a report of an adverse event involving mineral IV injection, Lot Number 11142013@74. 

Read More →

Hospira, Inc, Initiates Recall of One Lot of 2% Lidocaine HCl Injection

Topics: Compounding and Fda

Hospira, Inc, of Lake Forest, IL, has initiated a voluntary recall for one lot of Lidocaine HCl Injection, USP 2%, 5 mL Single-Dose Vial, National Drug Code 0409-4276-01, Lot 32-135-DD due to the presence of particulate matter.

Read More →

Teen Prescription Drug Abuse Remains Steady in 2013, Monitoring the Future Survey Finds

Topics: Prescription drug abuse

Results of the 2013 Monitoring the Future survey (PDF) show abuse of most types of prescription drugs among teens remained relatively stable in 2013. 

Read More →

Rx Formulations Recalls Some Sterile Products Due to Observed Floating Matter

Topics: Compounding and Fda

Rx Formulations of Mesa, AZ, and Food and Drug Administration (FDA) have announced a voluntary recall of some compounded sterile products after 2 to 3 millimeter, irregularly shaped floating matter was observed in an intact, unused vial of calcium gluconate injection produced at the facility.

Read More →

USP Adopts Labeling Standards for Ferrules and Cap Overseals to Protect Patient Safety

Topics: Patient safety, Prescription label, and Adverse drug events

United States Pharmacopeial Convention (USP) labeling standards for ferrules and cap overseals that require warning messages with vital information aimed to prevent imminent life-threatening situations became official on December 1, 2013.

Read More →

Event Registration for NIDA's Drug Facts Week for Teens Now Open

Topics: Education and Patient safety

In preparation for National Drug Facts Week (NDFW), community organizations are invited to register drug abuse awareness events online. 

Read More →

Study Finds Medication Synchronization Programs Improve Adherence Rates

Topics: Medication therapy management

Appointment-based medication synchronization programs improve patient adherence by 3.4 to 6.1 times, a study published in the November/December 2013 issue of the Journal of the American Pharmacists Association reports. 

Read More →

Voluntary Recall of HYDRAVAX Dietary Supplement Issued Due to Possible Undeclared Ingredient

Topics: Compounding and Fda

IQ Formulations of Sunrise, FL, is initiating a voluntary nationwide recall on all lots of its 45-capsule bottles of HYDRAVAX due to potential inclusion of an unlisted ingredient.

Read More →

National Influenza Vaccination Week Resources for Health Care Providers Available

Topics: Vaccinations

Centers for Disease Control and Prevention is encouraging health care providers to remind patients and caregivers of patients six months and older that it is not too late to get a flu vaccine.

Read More →

Baxter International Inc, Recalls One Lot of Nitroglycerin in 5% Dextrose Injection

Topics: Compounding and Fda

FDA and Baxter International, Inc, have issued a voluntary recall of one lot of nitroglycerin in 5% dextrose injection due to the presence of particulate matter found in one vial.

Read More →

Hospital Pharmacies Frequently Contacted by Opportunistic Vendors

Topics: Diversion and Pharmacies

Of 125 hospital pharmacy directors in Texas, more than 85% reported that they have been contacted by gray market vendors offering to sell drugs in short supply.

Read More →

Twitter Offers Insight into College Students’ Medication Misuse

Topics: Controlled substances and Prescription drug abuse

College students are taking to Twitter to talk about prescription drugs, often revealing how they misuse medications, according to two recent studies. 

Read More →

Prescription Drug Abuse Fastest Growing Drug Threat, Reports DEA

Topics: Prescription drug abuse

Prescription drug abuse continues to be the nation’s fastest growing drug problem, and abuse of controlled substance prescription drugs poses a significant drug threat to the United States, stresses the Drug Enforcement Administration (DEA) in 2013 National Drug Threat Assessment Summary. 

Read More →

Michigan Pharmacy Owner and Eight Employees Indicted for Misbranding and Reselling Returned Drugs

Topics: Diversion

A Michigan pharmacy owner and eight staff members have been indicted on charges of conspiracy to misbrand drugs.

Read More →

FDA Launches Responsive Design Web site for Easier Mobile Viewing

Topics: Fda

To better address the needs of its Web site users, Food and Drug Administration (FDA) has upgraded its Web site for improved viewing on tablets, smart phones, and other mobile devices. 

Read More →

Unapproved Male Enhancement Dietary Supplements Could Cause Dangerous Low Blood Pressure Levels, FDA Warns

Topics: Counterfeit drugs, Over the counter, and Fda

Food and Drug Administration is warning consumers about male lifestyle dietary supplements containing undeclared ingredients.

Read More →

Michigan Senate Bill Would Allow Medical Marijuana to Be Dispensed by Pharmacies

Topics: Medical marijuana

A Michigan law passed by the state’s Senate would allow patients to purchase medical marijuana from licensed pharmacies as a Schedule II controlled substance.

Read More →

New FDA Drug Info Rounds Training Videos Available

Topics: Education and Fda

FDA has published new Drug Info Rounds videos.

Read More →

DEA Reports Strong Turnout for Seventh Prescription Drug Take-Back Day

Topics: Diversion, Medication collection program disposal, and Dea

Drug Enforcement Administration reports that nearly 650,000 pounds of unneeded prescription medications were properly disposed of during the October 26, 2013 National Prescription Drug Take-Back Day.

Read More →

FDA Actions Aim to Reduce Drug Shortages

Topics: Federal regulations and Fda

In an ongoing effort to reduce drug shortages, Food and Drug Administration has released a strategic plan and has also proposed a new early notice rule for manufacturers. 

Read More →

2013 USP Chapter <797> Compliance Survey Shows Compliance Trends Unchanged From 2012

Topics: Compounding and Federal regulations

The 2013 United States Pharmacopoeia (USP) Chapter <797> Compliance Survey, the third annual report released since 2011, shows that the overall compliance rate of 77.2% remains nearly unchanged from the 2012 rate.

Read More →

One in 10 Teens Visiting Emergency Departments Reported Past Year Non-Medical Use of Prescription Drugs, Study Reports

Topics: Prescription drug abuse

As many as one in 10 teenagers who visited an emergency department (ED) reported abuse of prescription painkillers or sedatives within the last year, University of Michigan researchers report in a study published in Pediatrics.

Read More →

Pharmacy Owners, Pharmacists Indicted for Illegal Mail-Order Prescription Painkiller Scheme

Topics: Counterfeit drugs

Nine defendants, including three licensed pharmacists, face federal charges related to their alleged roles in operating a prescription painkiller ring on the East Coast, NBC News reports. 

Read More →

FDA to Recommend Reclassification of Hydrocodone Combination Products as Schedule II Controlled Substances

Topics: Controlled substances and Fda

Food and Drug Administration (FDA) plans to submit a formal recommendation to reclassify hydrocodone combination products as Schedule II controlled substances. 

Read More →

Consumers Encouraged to Ensure Online Pharmacies are Licensed, Legitimate in New FDA Video

Topics: Buying medicine online

Tip-offs that an Internet drug seller may be fraudulent include offering prescription drugs without requiring a valid prescription and too-good-to-be-true prices, warns a new FDA consumer video.

Read More →

Reminder: DEA Prescription Drug Take-Back Day Is Saturday, October 26

Topics: Medication collection program disposal and Dea

Americans throughout the country will have the opportunity to dispose of unneeded or unwanted medications at a Drug Enforcement Administration National Prescription Drug Take-Back Day collection site on Saturday.

Read More →

Massachusetts House Unanimously Approves Compounding Oversight Bill

Topics: Compounding

The Massachusetts House has passed a bill that would make random unannounced inspections of compounding pharmacies a permanent requirement.

Read More →

Pharmacy Owner Pleads Guilty to Illegally Selling Narcotics to Patients Without a Prescription

Topics: Counterfeit drugs and Diversion

Peter Riccio, owner of pharmacies in Hellertown and Palmer, PA, pleaded guilty to charges of illegal distribution of the drug butalbital, a Schedule II narcotic.

Read More →

Legal Briefs: 132,265 Bye Byes

Topics: Diversion and Pharmacists

On occasion, civil and criminal judicial decisions maintain relevance to the regulatory community and are of interest to boards of pharmacy. 

Read More →

Maine Law Allowing International Drug Imports Raises Safety Concerns

Topics: Counterfeit drugs, Buying medicine online, and Federal regulations

A Maine law allowing for the direct purchase of mail-order prescription drugs from foreign entities is facing legal challenges.

Read More →

Reminder: The Next DEA Prescription Drug Take-Back Day is Saturday, October 26, 2013

Topics: Medication collection program disposal and Dea

The next opportunity to dispose of any unneeded or unwanted medications at a Drug Enforcement Administration (DEA) National Prescription Drug Take-Back Day collection site will be Saturday, October 26, 2013. 

Read More →

Hospira, Inc, Recalls One Lot of 1% Lidocaine HCI Injection After Report of Particulate Matter

Topics: Compounding and Fda

Food and Drug Administration (FDA) and Hospira, Inc, of Lake Forest, IL, have issued a voluntary recall of one lot of 1% Lidocaine HCI Injection, USP, 10 mg/mL, 2 mL Multiple-dose Fliptop Vial, National Drug Code 0409-4276-01, Lot 25-090-DK. 

Read More →

California Enacts Two Laws Aimed to Reduce Prescription Drug Abuse

Topics: Prescription drug abuse and Prescription monitoring program

Governor Brown signed two bills into law that aim to reduce prescription drug abuse by enhancing the state’s prescription monitoring program and by making it easier for the medical board to investigate patient records after a suspicious death.

Read More →

FDA Provides New Information About Lack of Sterility Assurance for Drugs Dispensed by The Compounding Shop

Topics: Compounding, Adverse drug events, and Fda

Food and Drug Administration (FDA) is warning patients and health care providers that budesonide solution (for nasal irrigation), dispensed by The Compounding Shop of St Petersburg, FL, may be contaminated and should not be used or administered to patients. 

Read More →

FDA Requires Changes to Fentanyl Pain Patch Warnings

Topics: Adverse drug events and Fda

To reduce the risk of accidental exposure, FDA has announced new requirements that change the appearance of fentanyl pain patch warnings to make them more visible. 

Read More →

Florida Sees Continued Decreases in Prescription Drug Related Deaths

Topics: Prescription drug abuse

In Florida, deaths tied to prescription drugs dropped by 17.7% and deaths caused by oxycodone plunged by 41%, state officials announced in a recent report.

Read More →

‘Bath Salts’ Linked to Nearly 23,000 Emergency Room Visits in 2011

Topics: Patient safety

A group of drugs known as “bath salts” were linked to an estimated 22,904 visits to hospital emergency departments in 2011.

Read More →

State Senators Pressure Craigslist to Ban Illegal Prescription Drug Ads

Topics: Buying medicine online and Diversion

State senators from Nevada and California are calling on Craigslist to remove ads from its site that facilitate illegal distribution and diversion of narcotics.

Read More →

Michigan Lawmakers Consider Bill to Strengthen Compounding Regulations

Topics: Compounding

A series of bills have been introduced to the Michigan Legislature that would include several provisions intended to strengthen the regulation of compounding in the state.

Read More →

Threat of Antibiotic-Resistant Bacteria Growing, CDC Warns

Topics: Vaccinations

A new report from CDC warns that there is a growing threat of antibiotic-resistant strains of infectious diseases. 

Read More →

FDA Proposes Labeling Changes for ER/LA Opioids to Combat Abuse, Mandates Post-market Research

Topics: Pain management and Fda

To combat the misuse and abuse of extended-release and long-acting (ER/LA) opioids, Food and Drug Administration (FDA) is announcing class-wide label changes to ER/LA opioids, including a statement indicating the medications should be prescribed when the patient requires constant treatment of severe pain and when alternative methods are inadequate.

Read More →

Know Your Dose Campaign Offers Acetaminophen Safety Tips Ahead of Cold and Flu Season

Topics: Over the counter and Patient safety

With flu shots now available across the country, and consumers stocking home medicine cabinets ahead of the coming cold and flu season, the Acetaminophen Awareness Coalition has issued a consumer message to “Double Check, Don’t Double Up” on acetaminophen when treating winter illnesses.

Read More →

University Compounding Pharmacy Recalls Some Products Due to Lack of Sterility Assurance

Topics: Compounding and Fda

Food and Drug Administration (FDA) and University Compounding Pharmacy of San Diego, CA, have issued a voluntary recall of several products.

Read More →

New FDA Drug Info Rounds Training Video

Topics: Continuing education, Pharmacists, and Fda

FDA Drug Info Rounds, a series of online videos, provides important and timely drug information to practicing clinical and community pharmacists.

Read More →

Park Pharmacy & Compounding Center Recalls Two Compounded Sterile Preparations

Topics: Compounding

Food and Drug Administration (FDA) and Park Pharmacy & Compounding Center of Irvine, CA, have announced a voluntary recall of two lots of products that were dispensed to patients and distributed to physician offices by prescription in June and July 2013 in California, Florida, New Mexico, and Indiana.

Read More →

Indiana Medical Board to Adopt Emergency Opioid Prescribing Rules at Request of State Legislature

Topics: Diversion and Prescription drug abuse

The Medical Licensing Board of Indiana is considering emergency rules related to opioid prescribing as mandated by the state’s “pill mill bill” (SB 246), which was signed into law by Governor Mike Pence in May 2013. 

Read More →

CVS Aggregates Data to Identify and Cut Off Suspected Pill Mills

Topics: Controlled substances and Diversion

In an effort to reduce prescription drug abuse, CVS pharmacists have adopted an analytical system to help identify “pill mill” prescribers.

Read More →

FDA: Fluoroquinolone Drug Labels Must Provide Better Descriptions of Peripheral Neuropathy

Topics: Patient safety and Fda

Food and Drug Administration updated its label requirements for the drug labels on fluoroquinolone-based medications.

Read More →

FDA Reminds Health Care Providers to Not Use NuVision Pharmacy Products

Topics: Fda

After NuVision Pharmacy refused FDA’s most recent request to recall all of its sterile products, FDA is reminding health care providers not to use NuVision sterile products.

Read More →

Specialty Compounding, LLC, Clarifies Recall Information

Topics: Compounding

Specialty Compounding, LLC, clarified a recall of all lots of sterile compounded medications produced in its Texas facility.

Read More →

CHPA Files Petition to Expand Dosing Information on Acetaminophen Products for Young Children

Topics: Over the counter and Fda

The Consumer Healthcare Products Association (CHPA) has filed a citizen petition to FDA that asks the agency to provide convenient and accurate access to dosing information for children ages six months to two years.

Read More →

Risks of Buying Prescription Drugs from Illegal Online Sellers Highlighted in NBC Connecticut Report

Topics: Counterfeit drugs and Buying medicine online

The risks of ordering medications online and of receiving dangerous counterfeit products are highlighted in a recent NBC Connecticut report.

Read More →

Illegally Operating Wholesaler in Virginia Posed as Canadian Distributor, Owners Indicted

Topics: Counterfeit drugs and Diversion

US Department of Justice (DOJ) officials indicted 11 people on 17 different charges related to the illegal importation and distribution of non-Food and Drug Administration (FDA)-approved drugs into the US.

Read More →

UPS First Package Delivery Company to Join CSIP in Fight against Rogue Internet Drug Outlets

Topics: Buying medicine online

United Parcel Service (UPS) has become the first global package delivery organization to join the Center for Safe Internet Pharmacies (CSIP) as a strategic partner and board member.

Read More →

Specialty Compounding, LLC Recalls All Lots of Unexpired Sterile Products After Reports of Adverse Events

Topics: Compounding

Food and Drug Administration (FDA) has announced a voluntary recall of all lots of unexpired sterile products produced by Specialty Compounding, LLC, in Cedar Park, TX.

Read More →

GAO Issues Recommendations for Congress and the Secretary of Health and Human Services for Compounding Pharmacies

Topics: Compounding

In a July 2013 report, the United States Government Accountability Office (GAO) recommends that “Congress should consider clarifying FDA’s authority to oversee certain entities that compound drugs.”

Read More →

FDA Warns of Rare Skin Reaction in Patients Taking Acetaminophen

Topics: Over the counter and Patient safety

FDA has issued a Consumer Update that warns of rare but serious skin reactions that may occur in patients taking acetaminophen.

Read More →

Three New Alabama Laws Aim to Crack Down on 'Doctor Shopping' and Prescription Drug Abuse

Topics: Prescription drug abuse and Prescription monitoring program

Alabama Governor Robert Bentley has signed into law three bills aimed to reverse the state’s growing prescription drug abuse rate. 

Read More →

Illinois to Implement Medical Marijuana Pilot Program Under Law Approved by Governor Quinn

Topics: Medical marijuana

On August 1, 2013, Illinois Governor Pat Quinn signed into law the Compassionate Use of Medical Cannabis Pilot Program Act, making Illinois the 21st state to legalize some form of medical marijuana. 

Read More →

Nova Diabetes Care Recalls Up to 62 Million Blood Glucose Test Strips

Topics: Patient safety

Nova Diabetes Care and Food and Drug Administration (FDA) officials have announced a voluntary recall of 21 lots of blood glucose test strips.

Read More →

Kentucky Sees Slight Decline in Drug Overdose Deaths, Including Prescription Drug Overdose

Topics: Prescription drug abuse

According to a state report released in late July, drug overdose deaths in the state of Kentucky decreased by 19 to 1,004. 

Read More →

Domperidone Not FDA Approved, Should Not be Marketed in the US, FDA Stresses

Topics: Compounding and Patient safety

Food and Drug Administration (FDA) stresses that domperidone is not an FDA-approved drug, and that it may not be legally marketed in the US. 

Read More →

Healthy Life Chemistry Supplement Product Contains Anabolic Steroids, FDA Warns

Topics: Patient safety

FDA is warning consumers not to use a product marketed as a Vitamin B dietary supplement due to the presence of potentially harmful anabolic steroids. 

Read More →

FDA Takes Action to Stop Distribution of Illegal, Potentially Harmful Products Claimed to Treat Diabetes

Topics: Counterfeit drugs and Patient safety

FDA advises consumers not to use, and is taking action to remove from the market, illegal products claiming to treat diabetes.

Read More →

Proposed Law Calls for Commission to Focus on Prescription Drug Abuse Efforts

Topics: Prescription drug abuse

A bill calling for a 30-member commission to coordinate law enforcement and health agency efforts to combat prescription drug abuse was introduced to the United States Senate. 

Read More →

Five Individuals Charged With Diversion of Prescription Controlled Substances

Topics: Diversion and Dea

Five individuals have been indicted and arrested on charges related to their involvement in a prescription drug diversion scheme. 

Read More →

Montana Man Sentenced for Role in Distribution of Fake Cancer Drugs

Topics: Counterfeit drugs

Paul Bottomley of Montana forfeited nearly $6 million in cash and property and was sentenced to five years probation for his role in the scheme that imported fake cancer drugs into US clinics, ultimately reaching patients.

Read More →

FDA Raises Awareness About Safe Use of Acetaminophen

Topics: Over the counter

FDA is alerting consumers to be mindful of the amount of acetaminophen they take in order to prevent overdose and potential liver damage. 

Read More →

Attorneys General in Nebraska and Oklahoma Call On Google to Remove 'No Prescription Required' Ads from YouTube

Topics: Counterfeit drugs and Buying medicine online

Attorneys General are calling on Google to remove video ads from YouTube that promote rogue Internet sites marketing medications, including controlled substances, as “no prescription required” products.

Read More →

State and Federal Regulators Continue to Combat Rogue Internet Drug Sellers, US GAO Reports

Topics: Buying medicine online

While facing the challenges of investigating and prosecuting complex, global operations, federal agencies in the United States continue to take action against Web sites illegally distributing prescription drugs to US consumers.

Read More →

Distribution of Counterfeit Drugs to US Residents Via Rogue Internet Sites Continues to Grow, Reports CNN

Topics: Counterfeit drugs

The problem of counterfeit drugs distributed into the US via rogue Internet drug sellers is growing, FDA consumer safety officers told CNN’s Sanjay Gupta, MD, as part of a special report.

Read More →

More Women Dying of Prescription Painkiller Overdoses

Topics: Prescription drug abuse

Every day, approximately 18 women die from an overdose of prescription pain medication, reports the Centers for Disease Control and Prevention (CDC).

Read More →

DEA to Hold Next Prescription Drug Take-Back Day on October 26, 2013

Topics: Controlled substances and Dea

Drug Enforcement Administration (DEA) will provide another opportunity for consumers to dispose of unneeded and expired prescription drugs during the 7th DEA National Prescription Drug Take-Back Day, October 26, 2013.

Read More →

FDA Provides New Resources on Importance of Safe Storage and Disposal of Fentanyl Patches

Topics: Medication errors

As part of its efforts to prevent accidental exposure to fentanyl patches, FDA is providing new resources about safe storage and safe disposal of the patches.

Read More →

Thousands of Rogue Online Drug Sellers Shut Down During Operation Pangea VI

Topics: Counterfeit drugs and Buying medicine online

As part of the sixth annual International Internet Week of Action (IIWA), Food and Drug Administration (FDA) took action against more than 9,600 Web sites illegally selling drugs that included counterfeit, substandard, and other potentially dangerous products. 

Read More →

Consent Decree Prohibits New Jersey Pharmacy from Manufacturing, Distributing Drug Products

Topics: Compounding

Med Prep Consulting, Inc, has been prohibited from manufacturing, holding, and distributing drug products under a consent decree of permanent injunction entered against the pharmacy by a federal court. 

Read More →

AMA Policy Deems 'Inappropriate Queries' From Pharmacies an Interference With Practice of Medicine

Topics: Pharmacies, Pharmacists, and Prescription drug abuse

The American Medical Association (AMA) has adopted a resolution stating that the organization deems certain pharmacy inquiries relating to the verification of prescriptions to be “an interference with the practice of medicine and unwarranted.” 

Read More →

Patient Survey Reveals Poor Adherence to Prescribed Medication Therapy, Explores Adherence Predictors

Topics: Medication therapy management

Many Americans are not adhering to prescribed medication regimens, indicates a new patient survey commissioned by the National Community Pharmacists Association (NCPA). 

Read More →

Rugby Laboratories Enteric Coated Aspirin Recalled Due to Potential Mix-up With Acetaminophen Tablets

Topics: Over the counter

One lot of Rugby Laboratories enteric coated aspirin tablets, 81 mg, has been recalled to the user level. 

Read More →

ISMP to Launch Safety Alert Newsletter Providing Medication Error Prevention Information Tailored to LTCFs

Topics: Medication errors

With Institute for Safe Medication Practices (ISMP) Medication Safety Alert! publications making a significant impact on preventing medication errors, the organization will soon be providing a new resource tailored to long-term care facilities.

Read More →

FDA Confirms Presence of Microbial Growth in Main Street Family Pharmacy Products

Topics: Compounding

As a result of an investigation initiated in May 2013, FDA has identified bacterial and fungal growth in products compounded by Main Street Family Pharmacy of Newbern, TN. 

Read More →

'Plan B' Morning After Pill to Be Available OTC Without Age Restrictions, According to Federal Judge’s Ruling

Topics: Over the counter and Emergency contraception

A ruling by Judge Edward R. Korman, Eastern District Court of New York, will effectively make the Plan B® One-Step, or “morning after” contraceptive pill, available as an over-the-counter product with no age restrictions.

Read More →

Bills to Safeguard Medications Through National Tracking System Under Consideration in Congress

Topics: Compounding, Counterfeit drugs, and Patient safety

A bill aimed to ensure the security of pharmaceuticals in the drug supply chain has passed the United States House of Representatives. 

Read More →

FDA Announces Opportunity for Expansion of ‘Script Your Future’ Medication Adherence Program

Topics: Education

FDA has announced the availability of grant funds intended to support the National Consumers League (NCL) in expanding efforts to educate the public about medication adherence.

Read More →

FDA Allows Import of Injectable Nutritional Drugs Due to Product Shortage

Topics: Federal regulations

FDA will allow the import of injectable drugs used in total parenteral nutrition (TPN) due to a critical shortage of the products.

Read More →

Sandoz Recalls Two Lots of Methotrexate Sodium, USP Due to Particulate Matter

Topics: Patient safety

Sandoz US is voluntarily recalling two lots of methotrexate sodium, USP, 25 mg/mL, 40 mL vial injectable product because of particulate matter found during a routine test of samples. 

Read More →

NABP Testifies at US House Subcommittee Hearing Regarding Support for Federal Legislation to Distinguish Between Compounding and Manufacturing

Topics: Compounding

NABP expressed its support for federal legislation that would distinguish between compounding and manufacturing, in testimony presented at a United States House subcommittee hearing on May 23, 2013. 

Read More →

Illinois Legislature Passes Medical Marijuana Bill

Topics: Medical marijuana

Illinois would establish a four-year medical marijuana pilot program under a bill passed by the state’s Legislature and under review by Illinois Governor Pat Quinn.

Read More →

Three Additional Synthetic Cannabinoids Classified as Schedule I Drugs

Topics: Controlled substances and Dea

DEA has issued a final order temporarily placing three synthetic cannabinoids into Schedule I of the Controlled Substances Act (CSA). 

Read More →

NABP Expresses Support of Federal Legislation That Distinguishes Compounding From Manufacturing and Clarifies Regulatory Oversight

Topics: Compounding

National Association of Boards of Pharmacy ® (NABP®) has expressed its support for the Pharmaceutical Compounding Quality and Accountability Act.

Read More →

NABP’s .PHARMACY Proposal Passes Initial ICANN Evaluation

Topics: Buying medicine online and Internet pharmacy

Reaching a critical milestone in the generic Top-Level Domain (gTLD) approval process, the National Association of Boards of Pharmacy® (NABP®) application to own and operate the .PHARMACY domain suffix has passed the Internet Corporation for Assigned Names and Numbers (ICANN) initial evaluation.

Read More →

NABP 2013-2014 Executive Committee Inaugurated at 109th Annual Meeting in St Louis, MO

Delegates to the National Association of Boards of Pharmacy® (NABP®) 109th Annual Meeting, held May 18-21, 2013, in St Louis, MO, elected individuals to fill the president-elect, treasurer, and open member positions on the Association’s 2013-2014 Executive Committee.

Read More →

Karen M. Ryle, MS, RPh, Begins Term as NABP President During the Association’s 109th Annual Meeting

Karen M. Ryle, MS, RPh, began her term as president of the National Association of Boards of Pharmacy® (NABP® ) during the Final Business Session of the Association’s 109th Annual Meeting, May 18-21, 2013, in St Louis, MO. 

Read More →

Joseph L. Adams, RPh, Elected NABP President-elect at Association’s 109th Annual Meeting

Joseph L. Adams, RPh, was elected to serve as the 2013-2014 president-elect of the National Association of Boards of Pharmacy® (NABP®) during the Association’s 109th Annual Meeting, May 18-21, 2013, in St Louis, MO. 

Read More →

Edward G. McGinley, MBA, RPh, Elected NABP Treasurer at Association’s 109th Annual Meeting

Edward G. McGinley, MBA, RPh, was elected to serve as the 2013-2014 treasurer of the National Association of Boards of Pharmacy® (NABP®) during the Association’s 109th Annual Meeting, May 18-21, 2013, in St Louis, MO. 

Read More →

NABP Reelects James T. DeVita, RPh, to Serve as Member of Executive Committee at Association’s 109th Annual Meeting

James T. DeVita, RPh, was reelected to serve a second three-year member term, representing District 1, on the Executive Committee of the National Association of Boards of Pharmacy® (NABP®) during the Association’s 109th Annual Meeting, May 18-21, 2013, in St Louis, MO.

Read More →

Susan Ksiazek, RPh, Elected to Serve as Member of Executive Committee at Association’s 109th Annual Meeting

Susan Ksiazek, RPh, was elected to serve a three-year member term, representing District 2, on the Executive Committee of the National Association of Boards of Pharmacy® (NABP®) during the Association’s 109th Annual Meeting, May 18-21, 2013, in St Louis, MO.

Read More →

Gary Dewhirst, RPh, Elected to Serve as Member of Executive Committee at Association’s 109th Annual Meeting

Gary Dewhirst, RPh, was elected to serve a three-year member term, representing District 5, on the Executive Committee of the National Association of Boards of Pharmacy® (NABP®) during the Association’s 109th Annual Meeting, May 18-21, 2013, in St Louis, MO. 

Read More →

NABP Supports Federal Legislation Creating New Category of Manufacturer Under FDA Oversight, While Maintaining Board of Pharmacy Authority Over Compounding Pharmacies

Topics: Compounding

In testimony presented at a United States Senate Committee Hearing, NABP expressed its support of draft legislation that would create a new category of manufacturer to include entities that engage in large-scale production of sterile non-patient-specific drugs for distribution. 

Read More →

Products Produced by The Compounding Shop Should Be Quarantined Due to Lack of Sterility Assurance, Warns FDA

Topics: Compounding

Medications produced and distributed by The Compounding Shop of St Petersburg, FL, should not be administered to patients and should be quarantined, warns FDA. 

Read More →

US Senate Committee Proposes Legislation to Create Compounding Manufacturer Category to Be Under FDA Regulation

Topics: Compounding

Federal lawmakers have drafted legislation that would create a new category of drug compounders, “compounding manufacturers,” to be regulated by Food and Drug Administration (FDA). 

Read More →

NABP Updates VAWD Criteria, Continuing Efforts to Help Secure the Integrity of US Drug Supply Chain for the Protection of Public Health

Topics: Counterfeit drugs and Patient safety

To further protect the integrity of the United States drug supply chain, the National Association of Boards of Pharmacy® (NABP®) has updated the criteria for the Association’s Verified-Accredited Wholesale Distributors® (VAWD®) accreditation program. 

Read More →

Illegal Online Sellers Fuel Global Spread of Fake and Substandard Medications, International Collaboration Key in Response, Reports NABP

Topics: Buying medicine online and Internet pharmacy

The National Association of Boards of Pharmacy® (NABP®) recently issued a report emphasizing that the global distribution of counterfeit and substandard medications, fueled by illegal online sellers, demands an international response.

Read More →

Two Compounding Pharmacies Recall Sterile Products Over Sterility Assurance Concerns

Topics: Compounding

Two pharmacies have voluntarily recalled their sterile compounded products because of concerns associated with quality control processes and a lack of sterility assurance. 

Read More →

Reminder: Next DEA Prescription Drug Take-Back Day is April 27

Topics: Medication collection program disposal

The next opportunity to dispose of any unneeded or unwanted medications at a Drug Enforcement Administration (DEA) National Prescription Drug Take-Back Day collection site will be Saturday, April 27, 2013.

Read More →

House Committee Members Examine FDA’s Responsibilities Relative to the Meningitis Outbreak

Topics: Compounding

In a meeting last week, members of a House Energy and Commerce subcommittee stressed that Food and Drug Administration (FDA) could have done more to prevent the fungal meningitis outbreak that killed 53 people and sickened hundreds in late 2012.

Read More →

FDA Reports Unsanitary Conditions at Compounding Facilities, Calls for More Regulatory Authority

Topics: Compounding

FDA Commissioner Margaret A. Hamburg, MD, reported in a recent FDA blog article that agency inspectors encountered “objectionable conditions” at 30 of the 31 sterile compounding pharmacies they recently examined.

Read More →

Dallas Drug Makers Issue Voluntary Recall for Sterile Products

Topics: Compounding

FDA is warning health care providers to quarantine and cease use of sterile drug products from ApotheCure, Inc, and NuVision Pharmacy, two Dallas, TX, facilities.

Read More →

Tennessee Bill Would Allow Non-Patient-Specific Compounding During Drug Shortages

Topics: Compounding

Tennessee lawmakers are considering legislation that would enable compounding pharmacies to create medicines without patient-specific prescriptions during drug shortages and other times when a product is not commercially available.

Read More →

Congressional Report Highlights State Challenges in Regulating Compounding Pharmacies

Topics: Compounding

A report released by US Representative Ed Markey (D-MA) highlights the challenges states face in regulating compounding pharmacies and examines how the pharmacies are tracked and inspected.

Read More →

Nevada Pharmacy Recalls All Sterile Compounded Products

Topics: Compounding and Patient safety

Nevada-based Green Valley Drugs has issued a voluntary recall of all lots of all its compounded, repackaged drugs because of a lack of sterility assurance. 

Read More →

FSMB Live Webcast to Explore Multi-State Licensure

Topics: Pharmacist license

The Federation of State Medical Boards (FSMB) will provide a free, live Webcast Thursday, April 18, 2013, from its Annual Meeting in Boston, MA, of a panel discussion on current trends in multi-state licensure in health care. 

Read More →

Rx Open Web Site to Provide Pharmacy Status Information During Public Health Emergencies

Topics: Patient safety

The emergency pharmacy status reporting tool operated by Rx Response now goes by an easy-to-remember name, Rx Open, with a matching URL, www.RxOpen.org.

Read More →

Fentanyl Patches Should Be Stored and Disposed of Properly to Avoid Accidental Poisonings in Children

Topics: Patient safety and Adverse drug events

Fentanyl patches should be securely stored out of the sight and reach of children and disposed of properly, advises Food and Drug Administration (FDA).

Read More →

UPS Forfeits Shipping Profits from Illegal Online Drug Sellers

Topics: Diversion and Dea

United Parcel Service (UPS) agreed to forfeit $40 million in payments received from online entities illegally selling and distributing prescription drug products.

Read More →

FDA Calls for Legislation to Allow Federal Oversight of Entities Compounding Non-Patient-Specific Drugs

Topics: Compounding and Federal regulations

US Food and Drug Administration (FDA) has called for the development of legislation to establish appropriate, minimum federal standards for entities engaged in the compounding of non-patient-specific sterile drugs for interstate distribution, states FDA Commissioner Margaret Hamburg, MD.

Read More →

Legislation to Reschedule Products Containing Hydrocodone as Schedule II Drugs Introduced to Congress

Topics: Controlled substances and Prescription drug abuse

With the aim of curbing prescription drug abuse, bipartisan legislation that would reclassify drug products containing hydrocodone as Schedule II controlled substances (CS) was introduced to Congress on March 20, 2013.

Read More →

New Jersey Compounding Pharmacy Recalls All Compounded Products Due to Mold Contamination

Topics: Compounding

Med Prep Consulting, Inc, a New Jersey-based compounding pharmacy, voluntarily recalled all lots of all its compounded products after a Connecticut hospital discovered mold particles in five bags of an intravenous solution.

Read More →

Georgia Compounding Pharmacy Recalls All Sterile Products After Eye Infections Reported

Topics: Compounding

FDA is alerting health care providers and patients of a voluntary recall of all sterile products produced and distributed by Clinical Specialties Compounding Pharmacy (CSCP) of Augusta, GA. 

Read More →

FDA Releases New Consumer Video on Acetaminophen Safety

Topics: Education, Over the counter, and Patient safety

With the arrival of allergy season, FDA has a released a new video to help educate patients about safe use of medications containing acetaminophen.

Read More →

NABP Comments on FDA Drug Shortages Strategic Plan Stress Ensuring Safety When Non-Approved Drugs Are Used

Topics: Federal regulations

To protect the public health, Food and Drug Administration (FDA) should carefully consider using the exercise of enforcement discretion during drug shortages, urges NABP. 

Read More →

Legislation to Allow Foreign Mail-Order Pharmacies to Dispense to Patients in Maine Poses Danger to Public Health, Warns NABP

Topics: Counterfeit drugs and Patient safety

Stressing the potential danger to patients, NABP expressed its opposition to legislation introduced in Maine that would allow the dispensing of drugs from mail-order pharmacies located around the world.

Read More →

Former NECC Employees Reveal Compounding Facility's Conditions During 60 Minutes Segment

Topics: Compounding and Patient safety

Former New England Compounding Center (NECC) employees reveal how workload and facility conditions contributed to the tragic meningitis outbreak linked to the company’s contaminated drugs in a 60 Minutes segment.

Read More →

FDA Continues Inspections of Facilities Compounding Sterile Injectable Drugs

Topics: Compounding and Patient safety

Inspections of 30 entities engaged in compounding are underway by Food and Drug Administration (FDA) inspectors as part of the agency’s response to the 2012 meningitis outbreak linked to contaminated compounded injectable drugs.

Read More →

Pennsylvania Legislators Consider Bill to Establish Expanded State PMP

Topics: Diversion and Prescription drug abuse

Aimed to reduce prescription drug abuse and diversion, legislation that would establish an expanded PMP in Pennsylvania is under consideration by state lawmakers. 

Read More →

Legal Briefs: Administrative Order Not Subject to Stay

Topics: Pharmacists and Pharmacist license

The NABP membership consists of the regulatory boards regulating the profession of pharmacy. These boards are statutorily created and empowered and act in the interest of protecting the public. 

Read More →

Bill to Expand Pharmacists' Authorization to Vaccinate Passes Wyoming Senate

Topics: Pharmacists and Vaccinations

Pharmacists’ authority to vaccinate may be expanded in Wyoming under a bill that would allow pharmacists to prescribe and administer immunizations for individuals age seven and older.

Read More →

New York Doctor Pleads Guilty to Federal Charges of Illegally Distributing Oxycodone

Topics: Controlled substances, Diversion, and Dea

New York physician Felix Rodriguez pled guilty to the distribution of more than 1,000 oxycodone pills to individuals without legitimate medical need for the drug.

Read More →

Prescription Drug Misuse Contributes to Continued Increase in Overdose Death Rate

Topics: Prescription drug abuse

Prescription drugs were involved in 60% of drug overdose deaths, which increased for the 11th consecutive year, reports Centers for Disease Control and Prevention (CDC).

Read More →

Federal Legislation to Prevent Prescription Drug Abuse Introduced to Senate

Topics: Controlled substances and Prescription drug abuse

Aimed to address prescription drug misuse, addiction, and overdose deaths, the Prescription Drug Abuse Prevention and Treatment Act (SB 348) was reintroduced in the United States Senate.

Read More →

Institute of Medicine Recommends Actions for Fighting Substandard Drugs in the US and Globally

Topics: Buying medicine online, Diversion, and Vipps vet vipps

Cooperation among international pharmacy regulatory agencies and tightening the United States drug distribution chain would help protect global public health from substandard and falsified drugs, indicates a new report from the Institute of Medicine (IOM).

Read More →

April 2013 DEA Prescription Drug Take-Back Day Offers Consumers Another Opportunity for Convenient Medication Disposal

Topics: Medication collection program disposal and Dea

Consumers across the country will have another opportunity to help prevent abuse and misuse of prescription drugs by disposing of any unneeded or unwanted medications during the sixth Drug Enforcement Administration (DEA) National Prescription Drug Take-Back Day.

Read More →

FDA Reexamines Its Exercise of Enforcement Discretion Regarding Valid, Patient-Specific Prescriptions and Compounding Pharmacies

Topics: Compounding

In a letter (PDF) to PharMEDium Services LLC, Food and Drug Administration (FDA) Center for Drug Evaluation and Research indicates that it will no longer exercise enforcement discretion that allowed the company to produce non-patient specific drug products for distribution to hospitals across the country. 

Read More →

Surprise Inspections in Massachusetts Result in Cease and Desist Orders to 11 Compounding Pharmacies

Topics: Compounding

Partial or complete cease and desist orders were issued to 11 compounding pharmacies by the Massachusetts Department of Public Health (DPH).

Read More →

Another Counterfeit Cancer Medication Distributed in US, FDA Warns

Topics: Counterfeit drugs

FDA is alerting health care providers that an unapproved cancer medicine distributed by a United States company, Medical Device King (also known as Pharmalogical), is counterfeit.

Read More →

Progress Made in Implementing Recommendations Intended to Prevent Acetaminophen Overdose

Topics: Patient safety and Medication errors

Compelling progress has been made by stakeholders seeking to address the public health issue of acetaminophen overdose, indicates a white paper published by the National Council for Prescription Drug Programs (NCPDP).

Read More →

ISMP Publishes Survey Results on Compounding Practices

Topics: Compounding

A majority of respondents to a survey on compounding practices indicated that pharmacy technicians who work in sterile compounding should be certified or licensed. 

Read More →

New York Pharmacists’ Authority to Administer Flu Vaccinations Expanded Under Emergency Order

Topics: Vaccinations

Responding to epidemic proportions of flu in New York State, Governor Andrew Cuomo has passed emergency orders expanding pharmacists’ authority to vaccinate individuals against the illness. 

Read More →

FDA Committee Recommends Schedule II Classification for Drugs Containing Hydrocodone

Topics: Controlled substances and Prescription drug abuse

The Food and Drug Administration (FDA) Drug Safety and Risk Management Advisory Committee recommended reclassifying hydrocodone combination products as Schedule II controlled substances after a two-day meeting.

Read More →

Providers Should Ensure Only Diluted Forms of Acetic Acid are Used, ISMP Warns

Topics: Patient safety and Medication errors

The Institute for Safe Medication Practices (ISMP) has issued a National Alert Network (NAN) notice (PDF) advising that health care organizations should take immediate steps to ensure that only diluted acetic acid solutions are used in patient care.

Read More →

USP Seeks Candidates for Expert Panel on General Chapter <797> Pharmaceutical Compounding – Sterile Preparations

Topics: Pharmacists

USP is seeking qualified candidates to serve on the Pharmaceutical Compounding–Sterile Preparations Expert Panel.

Read More →

Canadian Citizen Sentenced to Four Years for Role in Internet Drug Outlet Operation

Topics: Diversion

Andrew J. Strempler, a Canadian citizen, was sentenced to four years in prison for charges related to the operation of a Web site illegally marketing and distributing prescription drugs to US residents. 

Read More →

Rx Response Offers Support for Areas Affected By Flu Outbreak

Topics: Patient safety

A spike in flu activity and limited supplies of vaccine and Tamiflu® doses across the country have prompted Rx Response to move its operations to Alert status.

Read More →

FDA Issues New Guidelines for Sleep Aids Containing Zolpidem

Topics: Adverse drug events

FDA has issued new dosing recommendations for sleep aids containing zolpidem.

Read More →

ISMP Launches Program to Track Vaccine Errors With Aim to Protect Patient Safety

Topics: Patient safety and Vaccinations

The Institute for Safe Medication Practices (ISMP) has launched a National Vaccine Error Reporting Program (VERP) that allows health care providers to confidentially report vaccine administration errors and near misses.

Read More →

Minnesota Board Implements Plan to Strengthen Regulation of Compounding Pharmacies

Topics: Compounding

The Minnesota Board of Pharmacy, which already has strong compounding regulations and requirements in place, is in the process of considering additional requirements, some of which will require the passage of new legislation. 

Read More →

California Board of Pharmacy Sponsors Legislation Authorizing Inspection of Nonresident Compounding Pharmacies

Topics: Compounding

The California State Board of Pharmacy will sponsor a bill that would allow inspectors to make unannounced on-site inspections of certain nonresident pharmacies.

Read More →

Massachusetts Governor Patrick Files Bill to Strengthen State’s Regulation of Compounding Pharmacies

Topics: Compounding

Massachusetts Governor Deval Patrick will file a bill that would strengthen the state’s regulation of compounding pharmacies. 

Read More →

ASOP and Google Help Warn Consumers About Online Dangers; European Partners Join ASOP Efforts

Topics: Buying medicine online and Internet pharmacy

Google has begun running search-based advertising aimed to help educate US consumers about illegal online drug sellers.

Read More →

FDA Warns Doctors About Unapproved Drug Products, Including Botox, Purchased from Foreign Suppliers

Topics: Patient safety and Prescription

Emphasizing risks to patient safety, Food and Drug Administration (FDA) has alerted more than 350 medical practices (PDF) across the country that they may have received unapproved medications.

Read More →

FDA to Hold Public Hearing on Use of Opioid Pain Medications

Topics: Patient safety and Prescription drug abuse

As FDA continues to seek a balance between minimizing opioid drug abuse and enabling the appropriate treatment of pain, the agency will hold a two-day public hearing to obtain information.

Read More →

House Bill Would Tighten Federal Regulations of Compounding Pharmacies

Topics: Compounding and Patient safety

In an attempt to tighten federal oversight of compounding pharmacies in the wake of the meningitis outbreak, the S.A.F.E. Compounded Drugs Act of 2012 (HR 6638) was introduced in Congress.

Read More →

NECC and Ameridose Closures Intensify Drug Shortages

Topics: Compounding and Patient safety

Hospitals and medical centers that relied upon the NECC and its sister company, Ameridose LLC, are suffering shortages of antibiotics, pain medications, and other drugs.

Read More →

NABP Leads the Charge as States Tighten Ranks Around Compounding Pharmacies

Topics: Compounding, Patient safety, and Pharmacists

Supporting state board of pharmacy efforts to enforce compounding regulations, the National Association of Boards of Pharmacy® (NABP®) is implementing a four-part action plan centered around inspection of nonresident compounding pharmacies and creating an information sharing network of regulatory details...

Read More →

Microbial Contamination Found in Additional NECC Products

Additional microbial contamination has been identified in three drug products at NECC. Centers for Disease Control and Prevention (CDC) and Food and Drug Administration (FDA) continue investigating NECC and have discovered bacteria and fungal species in unopened vials of betamethasone,...

Read More →

Grand Jury Begins Investigating NECC and Fungal Meningitis Outbreak

A federal grand jury is collecting information and evidence from people who worked with the New England Compounding Center (NECC), the pharmacy that produced contaminated steroid injections leading to a multistate outbreak of fungal meningitis affecting over 540 people. The...

Read More →

Massachusetts Department of Public Health Finds Storage and Preparation Problems at Three Compounding Pharmacies

The Massachusetts Department of Public Health has sent cease and desist orders to three compounding pharmacies for drug preparation and storage problems that were discovered during surprise inspections. The Boston Globe reports that the issues found at the facilities –...

Read More →